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Innate immunity is the primary defense mechanism that recognizes and 
respond to invading infectious microbes or their components, known as pathogen-
associated molecular patterns (PAMPs), or to danger signals that comes from self 
components, known as danger-associated molecular patterns (DAMPs). These 
molecules are recognized in our body by the so called pattern recognition receptors 
(PRRs), whose activation quickly gives rise to an important cascade of events known 
as acute inflammatory response. Within few hours, pro-inflammatory cytokines, such 
as TNFα, IL-1β and IL6, and chemokine, such as CCL2, CCL3 or CXCL8, are 
released in the blood stream, and innate immune cellular components are induced to 
combat the pathogens to the site of injury. Circulating neutrophils and monocytes are 
implicated as essential players in defense against a range of microbial pathogens. 
The acute inflammation process is a double-edge sword. Normally, it terminated 
once triggering insult is eliminated, the infection is cleared and damage tissue is 
repaired. Misregulation of one or more step from initiation to resolution can 
significantly contribute to the pathogenesis of autoimmune, chronic inflammatory or 
infectious diseases. For this reason, the inflammatory response itself and its 
termination phase are active and highly regulated processes involving several key 
regulatory mechanisms. 
MicroRNAs (miRNAs) are small noncoding RNAs recently emerged as 
powerful posttranscriptional regulators in various biological processes. A growing 
number of evidence suggests that the development and function of cells in the 
immune system is also subject to regulation by miRNAs, and in 2006 the first 
evidence on their potential involvement in inflammation control was provided by 
Taganov and colleagues, who reported a unique set of microRNAs (miR-146a, miR-
155 and miR-132) overexpressed in the THP-1 monocytic cell line after TLR4 
agonist engagement, and postulated that miR-146a may operate a negative feedback 
loop acting on TRAF6 and IRAK1, two keys adaptors in TLR4 signaling pathway. 
Moving from these information, this thesis project has characterized the complete 
microRNA expression profile induced by TLR4 activation in freshly purified human 
blood monocytes and neutrophils. Beyond the aforementioned miR-155, miR-146a 
and miR-132, a new set of molecules were first described as LPS-responsive 
miRNAs in monocytes, including miR-9, miR-187, and the miR-99b~7e~125a miR 
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cluster. This study also identified miR-9 as the only microRNA also up-regulated in 
neutrophils in a MyD88- and NF-κB-dependent manner and highlighted a new 
feedback regulatory loop acting at the NF-kB level, as miR-9 was demonstrated to 
directly target NFKB1 mRNA and post-transcriptionally modulating its expression. 
Inflammatory response triggers an important number of events that bring not 
only to propagation (producing pro-inflammatory mediators such as TNFα or IL-1β) 
but also to resolution. Two fundamental anti-inflammatory mediators whose release 
is induced by inflammation itself are IL-10 and glucocorticoids (GC), that act in a 
autocrine/paracrine or systemic manner, respectively.  
Our work has revealed that miR-187 and miR-99b~7e~125a miR cluster induction 
by LPS resulted by an IL-10-dependent loop. Bioinformatic tools and cellular and 
biochemical assays allowed us to uncovering the function of these new IL-10-
dependent miRNAs in the modulation of several proinflammatory cytokines and 
chemokines (TNFα, IL-6, CCL3, CXCL8) acting at different steps of the signaling 
pathway that bring to their production. Indeed, both the transcription factor IκBζ and 
the signaling complex TLR4/CD14 were found to be targets of miR-187 and miR-
99b~7e~125a miR cluster, respectively. These results underline a new mechanism 
for IL-10 in inducing pro-inflammatory genes silencing. In parallel, GC were shown 
to induce expression of miR-511 in a synchronized fashion with its host gene, the 
mannose receptor MRC1 (also known as CD206). Bioinformatic tools highlighted a 
relevant number of molecules involved in TGFβ signaling among miR-511 predicted 
target genes, and miR-511 was shown to block MAPK cascade and gene expression 
induced upon TGFβ stimulation. 
Taken together, these results suggest that miRNA represent an emerging 
mechanism active in leukocytes to dampen inflammation and avoid exacerbated 
inflammatory mediators release by a multitargeting strategy affecting several key 
signaling pathways and transcription factors. 
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Inflammation: from pathogen invasion to resolution 
 
How inflammatory reaction starts 
Inflammation is part of the complex biological response of tissues to harmful 
stimuli, such as pathogens, damaged cells, or irritants. It is a protective attempt by 
the organism to remove the injurious stimuli and to initiate the healing process.  
A typical inflammatory response consists of four components: inflammatory 
inducers, the sensors that detect them, the inflammatory mediators induced by the 
sensors, and the target tissues that are affected by the inflammatory mediators 
(Medzhitov, 2010). The type of pathway induced under given conditions depends on 
the nature of the inflammatory trigger. Thus, bacterial pathogens are detected by 
receptors of the innate immune system, such as Toll-like receptors (TLRs) (Janeway 
and Medzhitov, 2002), and thereby the amplification of the inflammatory response 
starts, due in part to cytokines generation: within 1 to 2 h after endotoxin exposure, 
blood levels of TNFα increase acutely, accompained by modest increases in IL-1β 
levels (Michie et al., 1988; Preas et al., 1996); in parallel, cytokines that 
downregulate cytokine production or their effect (IL-10, IL-1ra, IL-6) are also 
detected in the blood (Granowitz et al., 1991; Michie et al., 1988); finally, growth 
factors that recruit and activate cells from the bone marrow (G-CSF, GM-CSF) and 
chemokines (CXCL8, CCL2, CCL3) that activate and direct the migration of 
leukocytes are detected within hours after endotoxin administration (Martich et al., 
1991; Suffredini et al., 1995). 
These inflammatory mediators then act on target tissues, including local 
blood vessels, to induce vasodilation, extravasation of neutrophils, and leakage of 
plasma into the infected tissue. Neutrophils recruited from the circulation, 
macrophages, and mast cells seek and destroy invading pathogens. This process is 
aided by plasma components, including antibodies and complement. In addition, IL-
1β, TNFα, and IL-6 can have systemic effects when secreted in sufficient amounts 
(Suffredini et al., 1999). They induce liver cells to produce acute phase proteins such 
as C-reactive protein and coagulation factors, and they activate brain endothelium to 
produce prostaglandins, including the major proinflammatory prostaglandin, PGE2. 
Locally produced PGE2, in turn, induces specific populations of neurons in the 
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central nervous system to promote so-called sickness behavior: fever, anorexia, 
fatigue, sleepiness, and social withdrawal (Pecchi et al., 2009). Depending on the 
type of infection (bacterial, viral, or parasitic), the sensors, mediators, and target 
tissues vary such that the appropriate type of inflammatory response is induced.  
 
The cellular poin of view – the innate immune system 
Innate immunity covers many areas of host defense against pathogenic 
microbes, including the recognition of pathogen-associated molecular patterns 
(PAMPs) (Janeway, 1989). It is an evolutionarily ancient part of the host defense 
mechanisms: the same modules are found in plants and animals, meaning that it 
arose before the split into these two kingdoms (Hoffmann et al., 1999). Conversely, 
adaptive immunity is a relative newcomer on the evolutionary landscape. Because 
the mechanism of generating receptors in the adaptive immune system involves great 
variability and rearrangement of receptor gene segments, the adaptive immune 
system can provide specific recognition of foreign antigens, immunological memory 
of infection, and pathogen-specific adaptor proteins. However, no adaptive response 
can be initiated without a prompt activation of the innate immune system, that 
represent the firing line against pathogen invasion.  
Innate immunity also lies behind most inflammatory responses, that are 
triggered in the first instance by neutrophils, monocytes, macrophages and dendritic 
cells through their innate immune receptors. 
 
i. Neutrophils 
Neutrophils are classically characterized by their ability to act as phagocytic 
cells, to release lytic enzymes from their granules and to produce reactive oxygen 
intermediates (ROI) with antimicrobial potential (Borregaard, 2010). Recently, 
neutrophils were observed as cells that survive much longer than first suggested 
(Colotta et al., 1992) and can be induced to express genes encoding key 
inflammatory mediators, including complement components, Fc receptors, 
chemokines and cytokines (Cassatella, 1999). Recent data have also suggested that 
neutrophils can be polarized towards distinct phenotypes in response to 
environmental signals (Fridlender et al., 2009). Neutrophils express a vast repertoire 
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of PRRs, including all members of the Toll-like receptor (TLR) family with the 
exception of TLR3 (Hayashi et al., 2003). The sensing of pathogens and tissue 
damage activates the effector functions of neutrophils. These include the production 
of ROI, lytic enzymes and antimicrobial peptides, as well as more recently described 
neutrophil extracellular traps (NETs) (Brinkmann et al., 2004). Indeed, neutrophils 
can extrude extracellular fibrillary networks composed mainly of DNA, but also 
contain proteins from neutrophil granules. NETs act as a mesh that traps 
microorganisms and, in turn, facilitates their interaction with neutrophil-derived 
effector molecules. 
Cytokine production by neutrophils is controlled by regulatory mechanisms 
that act at different levels, including mRNA transcription (Cassatella, 1999), stability 
or translation (for example, through microRNA-mediated targeting, as in the case of 
mouse IFNγ (Yamada et al., 2011)), as well as protein secretion.  
Although neutrophils do not proliferate and have an estimated half-life of 
approximately 10–12 hours under in vitro culture conditions, signals such as 
adhesion, transmigration, hypoxia, microbial products and cytokines (Colotta et al., 
1992) can delay their programmed cell death and thus extend their survival in vivo. 
For example, macrophages can attract neutrophils to the site of injury and produce 
cytokines to control the lifespan and activity of the recruited cells (Soehnlein and 
Lindbom, 2010). On the other hand, as a key component of the inflammatory 
response, neutrophils make important contributions to the recruitment, activation and 
programming of APCs. Neutrophils generate chemotactic signals that attract 
monocytes and dendritic cells (DCs), and influence whether macrophages 
differentiate to a predominantly pro- or anti-inflammatory state. They also produce 
TNFα and other cytokines that drive DC and macrophage differentiation and 
activation.  
 
ii. Monocytes 
Neutrophils, macrophages, and dendritic cells (DCs) are important cellular 
mediators of innate immune defense. Circulating monocytes, however, are 
increasingly implicated as essential players in defense against a range of microbial 
pathogens. Monocytes represent 10% of leukocytes in human blood and 4% of 
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leukocytes in mouse blood. They are present in mammals, birds, amphibians, and 
fish (Hadji-Azimi et al., 1987; Herbomel et al., 1999; Kelly et al., 2000), and a 
related population of hemocytes (called plasmatocytes) is present in the fly 
(Williams, 2007), which does not have lymphocytes. Monocytes play an important 
role in development and homeostasis, in part via the removal of apoptotic cells and 
scavenging of toxic compounds (Williams, 2007). Strikingly, monocyte/macrophage 
specialization can already be observed among simple eukaryotic organisms, as 
phagocytes able to scavenge toxic compounds and kill bacteria differentiate inside 
colonies of social amoeba (Dictyostelium discoideum) (Chen et al., 2007a). 
Monocytes represent immune effector cells, equipped with chemokine receptors and 
adhesion receptors that mediate migration from blood to tissues during infection. The 
best known function of monocytes is as a considerable systemic reservoir of myeloid 
precursors for the renewal of some tissue macrophages and antigen-presenting 
dendritic cells (DCs) during inflammation and possibly, less efficiently, in the steady 
state (Randolph et al., 1999; Serbina and Pamer, 2006). Migration to tissues and 
differentiation to inflammatory DCs and macrophages are likely determined by the 
inflammatory milieu and pathogen-associated pattern-recognition receptors (Serbina 
et al., 2008). Monocytes have long been considered as a developmental intermediate 
between bone marrow precursors and tissue macrophages. It is now clear, however, 
that many DCs and tissue macrophages do not originate from monocytes in a steady 
state. Conversely, monocytes carry out specific effector functions during 
inflammation (Auffray et al., 2009). They produce inflammatory cytokines and take 
up cells and toxic molecules. Indeed, blood monocytes also represent a large pool of 
scavenger and potential effector cells inside blood vessels in homeostasis as well as 
during inflammatory processes (Auffray et al., 2007). Monocytes are equipped with a 
large array of scavenger receptors that recognize lipids and various microorganisms, 
and stimulated monocytes can produce large concentrations of ROI, complement 
factors, prostaglandins, nitric oxide (NO), cytokines such as TNFα, IL-1β, CXCL8, 
IL-6, and IL-10, vascular endothelial growth factor and proteolytic enzymes. They 
also have been involved in the defense against pathogen (Serbina et al., 2008). 
Antigen presentation has been described as a classical feature of monocytes, but 
since the identification of discrete subsets of DCs among monocyte cells, bona fide 
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monocytes have been found in most cases to be far less efficient than DCs for 
antigen presentation (Banchereau and Steinman, 1998). 
A peculiar feature of monocytes is their plasticity, which holds that 
monocytes respond to their environment by differentiating into a variety of 
macrophages and DC-like cells (Taylor and Gordon, 2003). This concept of 
plasticity is largely based on the effects of cytokines on monocytes in vitro. Exposure 
to granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 induces 
differentiation of human and mouse monocytes into DCs. Moreover, addition of 
transforming growth factor-β1 confers the phenotype of Langerhans Cells 
(Geissmann et al., 1998), whereas exposure to M-CSF induces monocytes to 
differentiate into macrophages. Addition of IFNγ and lipopolysaccharide to M-CSF-
differentiated macrophages (resting macrophages) induces the differentiation of M1-
like cells, whereas addition of IL-4 induces the differentiation of M2-like 
macrophages (Martinez et al., 2009).  
 
iii. Mononuclear Phagocyte system: macrophages and dendritic cells 
Macrophages and DCs form networks of phagocytic cells throughout most 
tissues, sometimes referred to as the Mononuclear Phagocyte System (MPS) (van 
Furth and Cohn, 1968), and play major roles in development, scavenging, 
inflammation, and antipathogen defenses. The MPS was initially defined as a 
population of cells, derived from a bone marrow progenitor, that differentiate and 
enter the blood as monocytes and then enter tissues to become resident tissue 
macrophages and antigen-presenting cells (van Furth and Cohn, 1968). However, it 
was soon recognized that DCs and macrophages have a remarkable heterogeneity 
related to their origin, phenotype, tissue localization, proliferative potential, and 
function (Geissmann et al., 2008). 
Current models propose that blood monocytes, many macrophage subsets, 
and most DCs originate in vivo from hematopoietic stem cell-derived progenitors 
with myeloid-restricted differentiation potential. Successive commitment steps in the 
bone marrow include common myeloid progenitors (CMPs), granulocyte-
macrophage precursors (GMPs), and macrophage/DC progenitors (MDPs). MDPs 
are a subset of proliferating cells in the bone marrow that share phenotypic 
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characteristics with myeloid precursor populations and give rise to many 
macrophages and DC subsets (Fogg et al., 2006) but largely cannot differentiate into 
granulocytes. Within the bone marrow, MDPs differentiate to monocytes and to the 
common DC precursors (CDPs). 
Macrophages are resident phagocytic cells in lymphoid and nonlymphoid 
tissues and have a broad role in the maintenance of tissue homeostasis, through the 
clearance of apoptotic cells and the remodelling and repair of tissues after 
inflammation (Gordon, 1998). Macrophages are equipped with a broad range of 
pathogen-recognition receptors that make them efficient at phagocytosis and induce 
production of inflammatory cytokines (Gordon, 2002). They derived from a common 
anchestor, but once spread in the organism, show a high degree of heterogeneity. The 
heterogeneity reflects the specialization of function that is adopted by macrophages 
in different anatomical locations: the ability of osteoclasts to remodel bone (Quinn 
and Gillespie, 2005); the high expression of pattern-recognition receptors and 
scavenger receptors by alveolar macrophages, which are involved in clearing 
microorganisms, viruses and environmental particles in the lungs (McCusker and 
Hoidal, 1989); the gut is one of the richest sources of macrophages in the body, and 
isolation of macrophages from the lamina propria has highlighted a unique 
macrophage phenotype that is characterized by high phagocytic and bactericidal 
activity but weak production of pro-inflammatory cytokines (Smythies et al., 2005). 
Mirroring T helper type 1–T helper type 2 (TH1-TH2) polarization, two distinct states 
of polarized activation for macrophages have been recognized: the classically 
activated (M1) macrophage phenotype and the alternatively activated (M2) 
macrophage phenotype (Martinez et al., 2008). Bacterial moieties such as LPS and 
the TH1 cytokine interferon-γ (IFN-γ) polarize macrophages toward the M1 
phenotype. In contrast, M2 polarization was originally discovered as a response to 
the TH2 cytokine IL-4 (Stein et al., 1992).  
Dendritic cells represent a heterogenous cell population, residing in most 
peripheral tissues, particularly at sites of interface with the environment (skin and 
mucosae), where they represent 1-2% of the total cell numbers (Banchereau and 
Steinman, 1998). Dendritic cells (DCs) are unique APCs because they are the only 
ones that are able to induce adaptive immune responses, thus permitting 
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establishment of immunological memory (Banchereau and Steinman, 1998). In the 
absence of ongoing inflammatory and immune responses, dendritic cells 
constitutively patrol through the blood, peripheral tissues, lymph and secondary 
lymphoid organs. A signal from pathogens, often referred to as a danger signal, 
induces dendritic cells to enter a developmental program, called maturation, which 
transforms dendritic cells into efficient antigen presenting cells (APCs) and T cell 
activators (Gallucci and Matzinger, 2001). Numerous factors induce and/or regulate 
DC maturation, including pathogen-related molecules such as LPS (Rescigno et al., 
1999), bacterial DNA (Akbari et al., 1999), and double-stranded RNA (Cella et al., 
1999); the balance between pro-inflammatory and anti-inflammatory signals in the 
local microenvironment, including TNFα, IL-1β, IL-6, IL-10, TGFβ, and 
prostaglandins and T cell-derived signals.  
Individual myeloid cell populations may share features of DCs and 
macrophages and can be difficult to ascribe to one or the other cell type. 
 
Sensing pathogens – Toll-like Receptors family and related proteins 
Microorganisms have various features that distinguish them from 
multicellular organisms. These features are known as “microbial patterns” and their 
detectors are defined as “pattern-recognition receptors” (PRRs) (Janeway, 1989). To 
initiate immune responses, PRRs recognize pathogen-associated molecular patterns 
(PAMPs) and induce several extracellular activation cascades such as the 
complement pathways and various intracellular signaling pathways, leading to 
inflammatory responses. The principal functions of pattern recognition receptors 
include opsonization, activation of complement and coagulation cascades, 
phagocytosis, activation of proinflammatory signaling pathways and induction of 
apoptosis.  
The innate immune system utilizes PRRs present in three different 
compartments: body fluids, cytoplasm and cell membranes. The PRRs in body fluids 
play major roles in PAMPs opsonization, the activation of complement pathways and 
in some cases the transfer of PAMPs to other PRRs. Complement components C3 
and C1q and a collectin family member MBL can activate complement pathways 
after PAMP recognition (Gasque, 2004). Pentraxin family members SAP, CRP and 
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PTX3 opsonize microbes for phagocytic clearance and/or activate the classical 
complement pathway (Garlanda et al., 2005; Gasque, 2004). Lipopolysaccharide-
binding protein (LBP) binds LPS, a major gram-negative bacterial cell wall 
component, and transfers it to membrane-bound CD14, a GPI-anchored, leucine-rich 
repeat (LRR) protein (Ulevitch and Tobias, 1995).  
Viruses and some bacterial pathogens can gain access to the intracellular 
compartments, such as the cytosol. Several pattern recognition receptors are 
expressed in the cytosol where they detect these intracellular pathogens and induce 
responses that block their replication. We can group cytoplasmic PRRs into three 
classes: interferon-inducible proteins, caspase-recruiting domain (CARD) helicases 
and nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs). IFN-
inducible proteins such as PKR and OASs (Stark et al., 1998) and CARD helicases 
such as RIG-I and MDA5 (Yoneyama et al., 2004) are involved in antiviral defense. 
In contrast, NLRs are mainly involved in antibacterial immune responses (Martinon 
and Tschopp, 2005).  
PRRs located on the cell membrane have diverse functions, such as the 
presentation of PAMPs to other PRRs, the promotion of microbial uptake by 
phagocytosis, and the initiation of major signaling pathways. Several cell surface 
receptors expressed on macrophages function as pattern recognition receptors that 
mediate phagocytosis of microorganisms. Macrophage mannose receptor (MRC1) is 
a member of the C-type lectin family and interacts with a variety of gram-positive 
and gram-negative bacteria and fungal pathogens. The main function of the MRC1 is 
thought to be phagocytosis of microbial pathogens and their delivery into the 
lysosomal compartment where they are destroyed by lysosomal enzymes (Fraser et 
al., 1998).  
TLRs are the best-characterized receptors among the PRRs. Their name 
reminds to their discovery. In Drosophila, Toll is a single-pass transmembrane 
receptor with an ectodomain marked by leucine-rich repeat motifs, originally 
identified for its essential role in development as the determinant of dorsoventral 
polarity in the fruitfly embryo. In addition, Toll was found to have a crucial role in 
immune defence. This second function of Toll was discovered by investigating the 
transcriptional regulation of antimicrobial genes that are induced by infection. 
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Subsequently, nuclear factor-κB (NF-κB) immune signaling, first identified in 
mammals, was suggested to occur in insects because NF-κB-binding motifs were 
identified in promoters of immunoresponsive genes in Drosophila (Sun et al., 1991). 
Surprisingly, the ligand for Toll in the immune response is not a microbial product, 
and so Toll is not a pattern-recognition receptor in fruitflys (Levashina et al., 1999). 
When administered to most mammalian species, LPS causes the prompt 
development of fever, disturbances in the clotting of blood, hypotension and shock 
(Ulevitch et al., 1984). All these effects are mediated by the activation of 
macrophages (Galanos and Freudenberg, 1993), which in turn release toxic 
cytokines, such as tumour necrosis factor (TNFα), that is known to provoke the 
release of terminal constituents of the inflammatory cascade (Beutler et al., 1985), 
and is considered to be largely responsible for LPS-induced lethality. The pathway 
through which LPS signals has been investigated extensively at a biochemical level. 
The LPS is driven to the surface of cells by the acute-phase protein LBP (LPS-
binding protein). There, it binds to the glycosylphosphoinositol-anchored membrane 
protein CD14, that lacks a transmembrane domain. How the LPS signal is transduced 
across membrane became clear only after analyis of C3H/HeJ and C57BL/10ScCr 
mice, whose genetic lesion, simply called Lps mutation, makes these mice 
unsusceptible to endotoxin shock after LPS systemic subministration. By a strict 
positional cloning approach, these mutations were found to affect the Tlr4 gene. In 
C3H/HeJ mice, a point mutation modified the cytoplasmic domain of the Tlr4 
protein creating a dominant-negative effect (Du et al., 1999). Later, a knockout 
mutation of Tlr4 (Hoshino et al., 1999) proved to be an excellent phenocopy of the 
C57BL/10ScCr mouse in terms of LPS response, confirming that the gene is required 
for LPS signal transduction. During 1999 and 2000, knockout mutations of Tlr2 and 
Tlr9 revealed that the former acts as a specific transducer for bacterial lipopeptide 
and peptidoglycan signals (Takeuchi et al., 1999), whereas the latter acts to detect 
bacterial DNA (Hemmi et al., 2000). The general impression of TLR function, 
therefore, is one in which each of the TLRs recognizes a discrete subset of those 
molecules that are widely shared by microbial pathogens. In this way, TLRs 
collectively provide protection against an immense number of microorganisms. 
All TLRs known in mammals are type I integral membrane glycoproteins 
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containing an extracellular domain with LRRs responsible for ligand recognition and 
a cytoplasmic Toll/IL-1R homology (TIR) domain required for initiating signaling 
(Akira and Takeda, 2004). Working as homo or heterodimers or with other PRRs, 
they recognize several ligands, consisting of bacterial cell wall components, bacterial 
genomic DNA, viral, fungal and parasitic products, and synthetic analogs of natural 
products. However, TLRs can also bind with autologous self-molecules such as heat 
shock proteins (HSPs), intercellular matrix products, and mammalian genomic DNA, 
revealing that the TLR immune system is concerned with damage signals from 
injured tissue, including endogenous ligands such as high mobility group box 1 
protein (HMGB1), HSPs (HSP22, HSP60, HSP70, HSP96), hyaluronan, type III 
repeat extra domain of fibronectin, uric acid crystals, mouse mammary tumor virus 
envelope proteins and respiratory syncytial virus fusion protein, β-defensin and plant 
ligands (paclitaxel) (O'Neill et al., 2009). It is suggested that TLRs recognize not 
only PAMPs, but also stress- or damage-associated molecular patterns (DAMPs) 
(Seong and Matzinger, 2004). 
TLRs 1, 2, 4, 5, and 6 are located mainly on the cell surface and primarily 
recognize bacterial components, but TLRs 3, 7, 8, and 9 are mostly on endocytic 
compartments and mainly recognize viral products (Akira et al., 2006). 
The model currently used to describe initiation of signaling (Figure 1) 
involves ligand- induced dimerization of TLRs, creating a TIR-TIR interface, which 
acts to recruit adapters via their TIR domains (Weber et al., 2005). Specificity is 
evident in adaptor usage by different TLRs. TIR-containing TLRs recruit the TIR-
containing cytosolic adaptors MyD88, TRIF (TIR domain–containing adaptor-	  
inducing IFN-β), MAL (MyD88 adaptor-like; also known as TIRAP), TRAM (TRIF-
related adaptor molecule) and SARM (sterile α and HEAT/armadillo motif protein) 
(Jenkins and Mansell, 2010; Kenny and O'Neill, 2008; O'Neill and Bowie, 2007). 
The canonical TIR pathway is dependent on MyD88, which is used by all TLRs 
except TLR3. The alternative pathway is controlled by another key adaptor, TRIF, 
the only TLR3 adaptor, with TLR4 binding both MyD88 and TRIF. The remaining 
three adaptors serve as coadaptors (MAL, TRAM) or as a negative regulator 
(SARM). The sorting adaptors MAL and TRAM are used by only some TLRs. MAL 
recruits MyD88 to TLR2 and TLR4, whereas TRAM recruits TRIF to TLR4 (O'Neill 
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and Bowie, 2007). Finally, SARM is supposed to be a negative regulator of TRIF 
(Carty et al., 2006). The TIR-containing adaptors recruit various molecules such as 
cytosolic kinases, including the IL-1R-associated kinase (IRAK) complex, leading to 
the sequential activation of IRAK4, IRAK1, and TNF receptor- associated factor 6 
(TRAF6) (Akira and Takeda, 2004). Then, the activated TRAF6 as an E3 ubiquitin 
	  
Figure 1. IL-1β/TLR signaling pathways. Activated TLRs and IL-1Rs recruit specific combinations of TIR- 
containing proteins (green spots). Specific TIR complexes activate specific kinase complexes (IRAKs or 
IKKε/TBK1), leading to the expression of specific genes via the NF-κB, AP1, and IRF transcription factors. 
 
ligase, together with an E2 ubiquitin-conjugating enzyme complex, ubiquitinates 
TRAF6 and IκB kinase γ (IKKγ) (also called NEMO) (Deng et al., 2000). The 
ubiquitinated TRAF6 is recruited to the TGFβ-activated kinase 1 (TAK1)-TAB1/2/3 
complex by binding to TAB2 (Chen, 2005). This promotes the activation of TAK1, a 
mitogen-activated protein (MAP) kinase kinase kinase (MAP3K), which in turn 
activates the canonical NF-κB activation pathway, leading to the expression of 
inflammatory cytokines (Chen, 2005). TAK1 also activates MAP kinases such as c-
Jun N-terminal kinases (JNKs) and p38, leading to the activation of AP-1 and thus 
the regulation of inflammatory cytokine expression (Wang et al., 2001). Finally, 
TRIF leads to IRF3 activation via recruitment of the IKKε/TBK1 (IκB kinase 
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ε/TANK-binding kinase 1), and this signal, in the case of both TLR3 and TLR4, 
comes from the endosome, with TLR4 trafficking there after LPS recognition (Kagan 
et al., 2008; Tanimura et al., 2008). The TRIF-mediated activation of IRF3 was 
shown to be essential in defence against virus, as it regulates the production of type I 
interferons (Yoneyama et al., 2004). A schematic representation of TLR signaling 
pathway is given in Figure 6.	  
Although all TLRs signal through the conserved signaling cascade described 
above, the complexity of the TLR-induced cellular responses indicates that there 
must be additional regulatory mechanisms and signaling pathways downstream of 
TLRs. One example is provided by the existence of a Rac1-PI3K-AKT pathway 
activated by TLR2. This pathway leads ultimately to phosphorylation of NF-κB and 
is necessary for NF-κB transactivation activity (Arbibe et al., 2000). Because Rac1, 
PI3K and AKT regulate diverse cellular functions in other pathways, this study also 
raises the interesting possibility of links connecting the TLR pathway to other 
signaling pathways. 
 
The inflammatory response as a genetic program 
Innate immune cells respond very rapidly to the presence of specific ligands 
signaling infectious danger that they recognize through pattern recognition receptors, 
as described below. Activation of TLR induces the expression of cytokines, 
chemokines, and other inflammatory mediators within less than 1 h. Two major 
signaling pathways are activated downstream of the TLR-induced MyD88-IRAK-
TRAF6 complex, which are essential for such a rapid response, and both involve the 
activation of the following latent transcription factors: 1) activation of the IκB kinase 
complex targets IκBs for degradation leading to nuclear translocation of active NF-
κB and 2) the MAPK pathway, a cascade of phosphorylation events that primarily 
results in the post-translational activation of several transcription factors, such as AP-
1. Both pathways synergize in inflammatory gene expression through coordinate 
binding of transcription factors to κB and AP-1 sites, often found together in the	  
promoters of many genes up-regulated in response to TLRs engagement. A 
schematic representation of what will be discussed here is given in Figure 6. 
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NF-κB system 
NF-κB is an eucaryotic transcription factor that exists in virtually all cell 
types. It was first described in 1986 as a nuclear factor necessary for 
immunoglobulin kappa light chain transcription in B cells (hence the name, nuclear 
factor-κB) (Sen and Baltimore, 1986). 
The basic scheme of NF-κB signaling consists of a series of positive and 
negative regulatory elements. Inducing stimuli trigger IKK activation leading to 
phosphorylation, ubiquitination, and degradation of IκB proteins. Released NF-κB 
dimers are further activated through various posttranslational modifications and 
translocate to the nucleus where they bind to specific DNA sequences and promote 
transcription of target genes. In its most basic form, therefore, the pathway consists 
 
Figure 2. Model of different NF-κB signaling pathways. Activation of the canonical pathway (left) depends on 
the IKK complex (IKKα–IKKβ–IKKγ/NEMO), which phosphorylates IκBα to induce its rapid degradation (IκBβ 
and IκBε are similarly regulated by IKK). The alternative pathway requires NIK and IKKα and induces the slow 
processing of p100 to p52, resulting in nuclear translocation of p52/RelB heterodimers. 
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of receptor and receptor proximal signaling adaptor molecules, the IKK complex, 
IκB proteins and NF-κB dimers (Hayden and Ghosh, 2008) (Figure 2).  
Mammals express five NF-κB proteins, namely RelA (p65), RelB, c-Rel, NF-
κB1 p50 and NF-κB2 p52. NF-κB1 and NF-κB2 are synthesized as large precursors 
of 105 (p105) and 100 kDa (p100) respectively that are processed by the proteasome, 
to produce the active NF-κB1 p50 and NF-κB2 p52 subunits. A common feature of 
all NF-κB proteins is the Rel-homology domain (RHD), that contains a nuclear 
localization sequence (NLS) and is involved in dimerization, sequence-specific DNA 
binding and interaction with the inhibitory IκB proteins (Ghosh et al., 1998). 
Although p50 and p52 lack a transcription activation domain, such a domain is 
present in RelA, RelB and c-Rel. The NF-κB proteins form numerous homo and 
heterodimers that are associated with specific biological responses that stem from 
their ability to regulate target gene transcription differentially. For instance, p50 and 
p52 homodimers function as repressors, whereas dimers that contain RelA or c-Rel 
are transcriptional activators. RelB exhibits a greater regulatory flexibility, and can 
be both an activator (Ryseck et al., 1992) and a repressor (Ruben et al., 1992). 
In its inactive state, NF-κB dimers are associated with one of three typical 
IκB proteins, IκBα (NFKBIA), IκBβ (NFKBIB), or IκBε (NFKBIE), or the precursor 
proteins p100 (NFKB2) and p105 (NFKB1). These IκBs maintain NF-κB dimers in 
the cytoplasm and are crucial for signal responsiveness. There are two inducibly 
expressed, atypical IκB proteins, Bcl-3 (BCL3) and IκBζ (NFKBIZ), that function 
quite differently in the regulation of NF-κB.	  The prototypical and most extensively 
studied member of the family is IκBα. IκBα is rapidly degraded during activation of 
canonical NF-κB signaling pathways leading to the release and activation of multiple 
NF-κB dimers, although the p65:p50 heterodimer is likely the primary target of 
IκBα. The nuclear NF-κB drives IκBα expression generating a negative feedback 
loop. IκBα, IκBβ, and IκBε, as traditional IκB proteins, sequester NF-κB dimers 
away from κB elements thus inhibiting transcription. The functional characteristics 
of IκBα, IκBβ, and IκBε are most likely a result of temporal differences in their 
degradation and resynthesis (Hoffmann et al., 2002). IκBβ and IκBε degradation and 
resynthesis occur with considerably delayed kinetics compared to that of IκBα.  
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NF-κB1 p105 and NF-κB2 p100, as precursors, can display IκB functions. 
Multiple reports have demonstrated that IKKβ-dependent phosphorylation of p105 
leads to complete degradation of the protein analogous to IκBα (Hayden and Ghosh, 
2004).  
Processing of p100 to p52 requires IKKα and is predominantly stimulus-
dependent (Senftleben et al., 2001). This process is recognized as alternative NF-κB 
activation pathway.	   This pathway is crucial for RelB activity, as RelB-containing 
dimers only associate with p100 and it has been suggested that they require p100 
binding for stabilization (Solan et al., 2002).  
The “Atypical” IκBs consist in two members, IκBζ and Bcl-3, that appear to 
regulate NF-κB signaling by a distinct mechanism. Bcl-3 is found in the nucleus 
associated with p50- and p52-containing homo and heterodimers. The mechanism of 
action of Bcl-3 is still not completely understood. Bcl-3 may mediate release of tran- 
scriptional repression by removing p50 homodimers from κB sites, thus acting as a 
traditional IκB but mediating activation by acting on repressive NF-κB dimers 
(Hayden and Ghosh, 2004). Alternatively, Bcl-3 may also stabilize repressive p50 
homodimers (Carmody et al., 2007). As a result, the induction of Bcl-3 expression 
inhibits subsequent NF-κB activation and may con- tribute to LPS tolerance in 
macrophages. 
IκBζ is not expressed constitutively but rather is upregulated in response to 
IL-1β and TLR4 ligands and upon expression localizes to the nucleus (Hayden and 
Ghosh, 2004). Most intriguingly in the absence of IκBζ, LPS- or IL-1-induced 
expression of a subset of NF-κB-regulated genes is lost (Yamamoto et al., 2004).	  
IκBζ is inducibly expressed following NF-κB activation and once expressed 
associates primarily with p50 homodimers. Furthermore, IκBζ is found associated 
with p50 on the promoter of IL-6, which is not inducibly expressed in IκBζ knockout 
cells, and it is, therefore, hypothesized that IκBζ acts as a coactivator for p50 
homodimers (Yamamoto et al., 2004). IκBζ has also been reported to negatively 
regulate p65-containing NF-κB complexes, and the slight elevation of NF-κB 
activity observed in IκBζ knockouts seems consistent with this (Motoyama et al., 
2005; Yamamoto et al., 2004). Thus IκBζ, like Bcl-3, may also be capable of 
selectively inhibiting or activating specific NF-κB dimers. 
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Degradation of IκB is a rapidly induced signaling event that is initiated upon 
specific phosphorylation of these molecules by activated IKK. The IKK complex 
contains two highly homologous kinase subunits, IKKα/IKK1 (CHUK) and 
IKKβ/IKK2 (IKBKB), and a regulatory subunit NEMO (NF-κB essential 
modulator)/IKKγ (IKBKG) (Hacker and Karin, 2006). Receptor engagement results 
in IKK activation, and the activated IKK complex phosphorylates IκBs, leading to 
their polyubiquitination and subsequent degradation via the 26S proteasome, thereby 
inducing nuclear translocation of NF-κB dimers (Karin and Ben-Neriah, 2000).	   
A remarkable diversity of stimuli lead to activation of NF-κB. These include 
both endogenous and exogenous ligands as well as a plethora of physical and 
chemical stresses. Signaling to NF-κB proceeds through intracellular adaptor 
proteins that allows their incorporation into various receptor-induced signaling 
events. Although there are exceptions, it appears that both canonical and non-
canonical pathways utilize TRAF family members for activation, while only 
canonical NEMO-dependent signaling to typical IκBs additionally requires RIP 
proteins (Hayden and Ghosh, 2008).  
TRAFs are key intermediates in nearly all NF-κB signaling pathways. As 
discussed above, in TLR/IL-1R signaling TRAF6 is recruited to the receptor 
complex and is necessary for MyD88-dependent activation of NF-κB (Kawai and 
Akira, 2007). TRAF6 is recruited to MyD88 in a manner dependent on IRAK 
proteins and RIP1, another key adapter in at least canonical NF-κB activation (Kawai 
and Akira, 2007).  
Receptor-interacting proteins (RIPs) appear to act both upstream of and with 
TRAF proteins to activate IKK. In fact, it is thought that RIPs may act as adapters 
and scaffolds in facilitating TRAF-induced IKK activation (Lee et al., 2004; 
McCarthy et al., 1998), as well as in TRIF-dependent NF-κB activation via TLR3 
and TLR4 (Cusson-Hermance et al., 2005). Following recruitment by IRAKs, 
TRAF6 binds to the TAB1/2/3 complex, leading to TAK1-mediated IKK activation 
(Wang et al., 2001). In noncanonical pathways NIK is instead required for IKKα 
activation and p100 phosphorylation (Senftleben et al., 2001; Xiao et al., 2001). 
Despite the clear requirement for TAK1 in multiple signaling pathways to IKK, the 
mechanism of action of TAK1 in signaling to NF-κB remains unclear. It is generally 
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agreed that this complex is needed for JNK and p38 activation (Sato et al., 2005). 
Indeed, a TAK1:TAB1 fusion protein is constitutively active and capable of 
stimulating AP-1 activity (Sakurai et al., 2002). 
 
MAP kinase cascade – AP-1 activation 
Mitogen-activated protein kinases (MAPKs) are protein Ser/Thr kinases that 
convert extracellular stimuli into a wide range of cellular responses. MAPKs are 
among the most ancient signal transduction pathways and are widely used 
throughout evolution in many physiological processes. All eukaryotic cells possess 
multiple MAPK pathways, which coordinately regulate gene expression, mitosis, 
metabolism, motility, survival, apoptosis, and differentiation. 
 
Figure 3. Mammalian MAP kinase pathways. The activation of MAPK signaling pathways is achieved through 
a triple kinase cascade: MAPKs are activated by dual phosphorylation on Thr and Tyr caused by specific MKKs. 
The MKKs are activated, in turn, by MKKKs. ERK1/2 can be activated by a specific signaling pathway that 
involve Ras downstream molecules, whereas p38s and JNKs share several MAPKKKs that selectively activate 
MEK3/6 or 4/7 with a ratio that determines the final outcome. 
 
Three main families of MAP kinases (MAPKs) exist in mammalian species, 
grouped by their structures and functions: the extracellular signal-regulated protein 
kinases (ERKs), the p38 MAPK, and the c-Jun NH2-terminal kinases (JNKs) 
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(Schaeffer and Weber, 1999). All the MAPKs consist of a Thr-X-Tyr (TXY) motif 
within their activation loop. The phosphorylation of both threonine and tyrosine 
within the activation loop is essential and sufficient for their activation. The ERK 
family contains a TEY (Thr-Glu-Tyr) activation motif (Cobb and Goldsmith, 1995). 
The p38 family	   has a TGY activation motif and includes α, β, γ and δ. There are 
three members in the JNK family which all contain Thr-Pro-Tyr (TPY) in their 
activation motif (Kyriakis et al., 1994). Each group of conventional MAPKs is 
composed of a set of three evolutionarily conserved, sequentially acting kinases: a 
MAPK, a MAPK kinase (MAPKK), and a MAPKK kinase (MAPKKK). The 
MAPKKKs, which are protein Ser/Thr kinases, are often activated through 
phosphorylation and/or as a result of their interaction with a small GTP-binding 
protein of the Ras/Rho family in response to extracellular stimuli. MAPKKK 
activation leads to the phosphorylation and activation of a MAPKK, which then 
stimulates MAPK activity through the dual phosphorylation described above 
(Cargnello and Roux, 2011) (Figure 3). 
Multiple mechanisms present in the MAPK signaling pathways ensure the 
fidelity and efficiency of the signaling flow. These mechanisms include the 
interaction between the kinase catalytic domain and the substrate phospho-acceptor 
site, docking interactions between members of a particular MAPK cascade and 
scaffold proteins (Zhang and Dong, 2007). 
Downstream of the MAPK, a large number of substrates that are 
serine/threonine-phosphorylated have been defined, including transcription factors of 
the ATF/CREB and AP-1 family, kinases such as Mapkapk2/MK2 and RSK, and 
proteins controlling mRNA stability and translation. Although there is some overlap 
in the target proteins of MAPK, prototypic-specific downstream mediators have also 
been defined using specific pharmacological inhibitors. These studies demonstrated 
the importance of MAPK activation in cytokine and chemokine gene expression in 
general, and provided many specific examples of genes that are regulated 
preferentially by one or the other MAPK. For example, IL-10 production was 
inhibited by the Map2k1/MEK1 inhibitor U0126, whereas IL-12 expression was 
suppressed by inhibition of p38 with SB203580 (Yi et al., 2002). Furthermore, 
higher IL-12 production from DC than from macrophages after stimulation was 
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inversely correlated with differences in the amount of ERK activation between the 
cell types (Hacker et al., 1999). The concept that the pattern of MAPK activation 
may determine the type of cytokine output was further supported by investigations 
into the activation of MAPK by different TLR ligands inducing reciprocal patterns of 
secretion of the immunosuppressive cytokine IL-10 and the Th1-driving IL-12. High 
levels of IL-10 along with low IL-12 production in response to TLR2 stimulation 
were shown to correlate with strong ERK activation, whereas TLR4, TLR5, or TLR9 
ligands preferentially activated p38 and induced more IL-12 (Agrawal et al., 2003; 
Dillon et al., 2004). Through the use of ERK1- and Fos-deficient macrophages, a	  
pathway could be delineated that controls the ratio of IL-10 vs IL-12 production with 
strong ERK activity stabilizing and enhancing the transcription of Fos that in turn 
supports IL-10 production and inhibits IL-12 (Pulendran, 2005). Similar conclusions 
could be made from studies showing Th-2 type adjuvant activity of TLR2 ligands in 
vivo (Redecke et al., 2004) and IL-10-promoting effects of ERK-activation by 
Leishmania phosphoglycans (Feng et al., 1999). Thus, the MAPK pathway is used in 
innate immunity not only to deliver the alarm signals from TLR on fast-track to the 
nucleus, but also it provides a means to translate the nature of the stimulus into 
appropriate responses by balancing the strength of individual MAPK signals. 
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Firefighting: from inflammation to resolution 
 
Detection of pathogens by innate immune cells triggers a robust and essential 
inflammatory reaction, known as acute inflammation, that can promote tissue repair, 
but it can also damage host tissues. The detrimental effects are further exacerbated in 
a chronic inflammatory state, which has been linked to a diverse range of diseases, 
including inflammatory autoimmune diseases, atherosclerosis, and cancer (Foster 
and Medzhitov, 2009). Chronic inflammation arises as a result of the continual 
presence of a stimulus or to genetic or physiological alterations that disrupt normal 
feedback mechanisms for attenuating the response. 
Thanks to its stereotypic features acute, systemic inflammation can be 
divided into phases that generate distinct clinical phenotypes: an initiation 
(proinflammatory) phase, an adaptive (anti-inflammatory and reparative) phase, and 
a resolution (restoration of homeostasis) phase (Kimbrell and Beutler, 2001). These 
phases are reflected by changes from hyperinflammation to hypoinflammation to 
resolution. As already described, to sense pathogens, our immune system virtually 
always uses TLRs to incite transcription of multiple proinflammatory genes, such as 
TNFα and IL-1β, whose products generate the initiating phase (Cavaillon et al., 
2005). This early phase is rapid and transient, terminating within hours by events that 
disrupt acute phase signaling transactivation through post-translational protein 
deactivation (Saccani et al., 2003), proteosome-dependent degradation (Saccani et 
al., 2004), and increased mRNA degradation (Hao and Baltimore, 2009), giving way 
to a well known adaptive phase called endotoxin tolerance (ET) (Beeson, 1947). 
During this phase, cells or organisms exposed to low concentrations of endotoxin 
(first demonstrated using LPS) enter into a transient unresponsive state and are 
unable to respond to further challenges with endotoxin. In other words, they develop 
a kind of “tolerance” to endotoxin. This phenomenon was firstly observed in vivo. 
Prior injection of mice with a sublethal dose of LPS protected them from a 
subsequent dose of LPS. These studies with mice demonstrated 
monocytes/macrophages as the principal cells responsible for the induction of ET in 
vivo (Cavaillon and Adib-Conquy, 2006). Subsequently, in vitro ET models 
confirmed that mouse macrophages as well as human monocytes exposed to 
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suboptimal levels of endotoxin show an inability to respond to further LPS 
challenge. The key readout for ET in these cells was the drastic reduction of TNFα 
	  
Figure 4. Local and systemic contribution in inflammation development and resolution. Phase I: patrolling 
monocytes and resident macrophages are the first cells to sense a disturbance in tissue homeostasis. They rapidly 
produce cytokines and chemokines to alert the immune system and to recruit neutrophils. Phase II: neutrophils 
invade the site of injury and release granule contents that promote the extravasation of inflammatory monocytes. 
Exudate formation, tissue swelling, and inflammatory mediators are responsible for “inflammatory pain,” and 
nociception complements inflammatory sensors in monitoring tissue homeostasis. Phase III: the life-span of 
emigrated neutrophils is rather short and is subject to modification by pro- or anti-apoptotic signals, some of 
which are produced by macrophages. Macrophages and apoptotic neutrophils prevent further infiltration of 
neutrophils, but signals from apoptotic neutrophils promote continued monocyte influx. Phase IV: the clearance 
of apoptotic neutrophils, anti-inflammatory cytokines production and increasing amount of cortisol released by 
surrenal gland in response to Hypothalamic-Pituitary-Adrenal axis promotes an anti-inflammatory programme in 
monocytes and macrophages, which leads, ultimately, to the reconstitution of tissue homeostasis. 	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production as compared to the cells exposed to endotoxin only once (del Fresno et 
al., 2009; Dobrovolskaia and Vogel, 2002; Foster et al., 2007). 
This “silencing” phase does not globally deactivate monocytes and 
macrophages, because expression of anti-inflammatory mediators and antimicrobial 
effectors is not inhibited and has been termed “TLR reprogramming” (McCall and 
Yoza, 2007). Poor inflammatory capacity coupled with upregulation of anti-
inflammatory cytokines would contribute to protection against septic shock and 
increased phagocytosis would allow efficient bacterial clearance. 
As already affirmed, an excessive inflammatory response is detrimental due 
to its negative effect on tissue function, as it can result in tissue damage. However, 
also a dysregulation of the resolution of inflammation may similarly contribute to 
tissue pathology. While ET has been thought as a protective mechanism against 
septic shock and ischaemia, its incidence is associated with high risks of secondary 
infections. For example, in sepsis, mortality due to secondary infection is associated 
with the incidence of a tolerant state (Monneret et al., 2008). Similarly, in acute 
pulmonary syndromes and cystic fibrosis, ET relates to an increased susceptibility to 
nosocomial infectious (del Fresno et al., 2009). Therefore, exactly like inflammation 
establishment, also its resolution phase must be finely regulated. 
Anti-inflammatory cytokines such as IL-10 and TGFβ and glucocorticoid 
hormones are considered as important agents in supporting endotoxin tolerance 
(Parrillo, 1993) and, in general, inflammation resolution (Figure 4). 
 
TGFβ and IL-10 – anti-inflammatory cytokines with autocrine and paracrine 
effects 
SMAD-dependent and SMAD-independent TGFβ-induced cellular response 
TGFβs are regulatory molecules with pleiotropic effects on cell proliferation, 
differentiation, migration and survival that affect multiple biological processes, 
including development, carcinogenesis, fibrosis, wound healing and immune 
responses (Blobe et al., 2000). The TGFβ system originated before the divergence of 
arthropods from vertebrates, developing several and complex functions in higher 
organisms (Newfeld et al., 1999). The first observation of TGFβ regulation of 
immune cell functions was made by Kehrl and colleagues (Kehrl et al., 1986) in 
	   32	  
1986, as the generation and analysis of TGFβ1-/- mice established a central role for 
this cytokine in inhibiting inflammation and autoimmune diseases.  
TGFβs belong to the TGFβ superfamily, with additional members including 
bone morphogenetic proteins, activins, and growth differentiation factors (Chang et 
al., 2002). There are three homologous TGFβ isoforms in mammals, TGFβ1, TGFβ2, 
and TGFβ3, encoded by different genes. TGFβ1 is the predominant isoform 
expressed in the immune system, but all three isoforms have similar properties in 
vitro (Govinden and Bhoola, 2003).  
TGFβ exerts the greatest impact on T lymphocytes and, in general, on 
adaptive immunity. In parallel, it has contrasting effects on innate immunity, in 
particular on monocytes/macrophages lineage, whose regulation appears to depend 
on the differentiation stage of the cells. Generally, TGFβ stimulates cells at the 
resting state (monocytes), whereas differentiated/activated cells (macrophages) are 
inhibited (Ashcroft, 1999). In fact, TGFβ recruits monocytes to the site of injury or 
inflammation via multiple mechanisms: it acts as a chemoattractant for monocytes 
(Wahl et al., 1987); it induces adhesion molecules, including LFA-1 and the 
fibronectin receptor on monocytes, enabling their attachment to extracellular matrix 
(Wahl et al., 1993); it induces matrix metalloproteinases (MMPs), which can 
dissolve vascular membranes and facilitate monocyte transmigration (Wahl et al., 
1993). In addition, TGFβ potentiates inflammation through induction of pro-
inflammatory cytokines, such as IL-1β and IL-6, in monocytes (Turner et al., 1990; 
Wahl et al., 1987). These observations reveal a proinflammatory function for TGF-β 
on monocytes. Once monocytes differentiate into macrophages, TGFβ functions 
mostly as an inhibitory molecule. In fact, TGFβ can negatively modulate expression 
of scavenger receptors and it inhibits its phagocytosis capacity. In vitro, TGFβ 
inhibits the expression of several LPS-induced inflammatory mediators such as 
TNFα and MMP-12 as well as chemokines including CCL3 and CXCL2 (Bogdan et 
al., 1992). Moreover, TGFβ can affect macrophage response to LPS down 
modulating CD14 expression (Imai et al., 2000) and promoting MyD88 degradation 
(Naiki et al., 2005). In addition, TGFβ inhibits expression of the costimulatory 
molecule CD40 and the inflammatory cytokine IL-12p40, which collectively results 
in the inhibition of the antigen-presentation function of macrophages (Takeuchi et 
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al., 1998). This inhibition may play an important role in resolving an ongoing 
immune response by diminishing secondary stimulation of T cells at the site of 
infection. 
A TGFβ ligand initiates signaling by binding to and bringing together type I 
and type II receptor serine/threonine kinases on the cell surface. This allows receptor 
II to phosphorylate the receptor I kinase domain, which then propagates the signal 
mainly through phosphorylation of the Smad proteins. There are eight distinct Smad 
proteins, constituting three functional classes: the receptor-regulated Smad (R-
Smad), the Co-mediator Smad (Co-Smad), and the inhibitory Smad (I-Smad). R-
Smads (Smad1, 2, 3, 5, and 8) are directly phosphorylated and activated by the type I 
receptor kinases and undergo homotrimerization and formation of heteromeric 
complexes with the Co-Smad, Smad4. The activated Smad complexes are 
translocated into the nucleus and, in conjunction with other nuclear cofactors, 
regulate the transcription of target genes. The I-Smad, Smad6 and Smad7, negatively 
regulate TGFβ signaling by competing with R-Smads for receptor or Co-Smad 
interaction and by targeting the receptors for degradation (Shi and Massague, 2003). 
The receptor serine/threonine kinase family in the human genome comprises 
12 members, 7 type I and 5 type II receptors, all dedicated to TGF signaling 
(Manning et al., 2002). Binding to the extracellular domains of both receptor types 
by the dimeric ligand induces a close proximity and a productive conformation for 
the intracellular kinase domains of the receptors, facilitating the phosphorylation and 
subsequent activation of the type I receptor. 
Among the three classes of Smads, only R-Smads are directly phosphorylated 
and activated by the type I receptor kinases. Smad2 and Smad3 respond to signaling 
by the TGFβ subfamily and Smads 1, 5, and 8 primarily by the BMP subfamily 
(Manning et al., 2002). Phosphorylation occurs also subsequently to interaction with 
other signaling pathways. Smads activity can be positively regulated by MAP 
kinases. Both Erk and JNK module target R-Smad enhancing heterodimerization 
with Smad4, nuclear translocation and transcription activation. On the contrary, 
ubiquitination of both R-Smad and Smad-associated TGFβ receptors, that occurs 
through TGFβ-activated Smurf family protein, designs them to degradation by the 
26S proteasome (Derynck and Zhang, 2003). 
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Cell stimulation with TGFβ leads immediately to positive and negative 
changes in the expression of several hundred genes (Kang et al., 2003). Both 
activation and repression of gene expression use the same set of activated Smad 
proteins. Further compounding this complexity, many of these gene responses 
depend on the cell type and other conditions affecting the cell at the time of TGFβ 
stimulation. A general hypothesis for how cells read TGFβ signals posits that Smad 
access to target genes and the recruitment of transcriptional coactivators or 
corepressors to such genes depend on cell-type specific partner proteins (Massague, 
2000) and on Smad-independent signaling activated by TGFβ itself (Derynck and 
Zhang, 2003). Indeed, besides Smad-mediated transcription, TGFβ activates other 
signaling cascades, including MAPK pathways.  
TGFβ can activate the Erk, JNK and p38 MAPK kinase pathways. Activation 
with slow kinetics in some cases may result from Smad-dependent transcription 
responses, but the rapid activation (5–15 min) in other cases suggests independence 
from transcription. Studies using Smad4-deficient cells or dominant-negative Smads, 
support the possibility of MAPK pathway activation that is independent from Smads 
(Engel et al., 1999). In addition, mutated TGFβ type I receptors, defective in Smad 
activation, activate p38 MAPK signaling in response to TGFβ (Yu et al., 2002). 
Rapid activation of Ras by TGFβ in epithelial cells may implicate Ras in TGFβ-
induced Erk MAPK signaling (Yue and Mulder, 2000). JNK and p38 MAPK 
signaling are activated by various MAPK kinase kinases (MAPKKKs) in response to 
many stimuli. Both TGFβ and BMP-4 can activate TGFβ-activated kinase 1 (TAK1), 
a MAPKKK family member (Sakurai et al., 2002). MEKK1 may also function 
upstream of TGFβ-mediated activation of MAPKKs; thus, MEKK1 and TAK1 could 
activate JNK through MAPK kinase 4 (MKK4), and p38 MAPK through MKK3 or 
MKK6, in response to TGFβ. Because TAK1 can phosphorylate and activate IkB 
kinase, thus stimulating NF-κB signaling, TGFβs induce also NF-kB signaling. As 
described above,	  TGFβ-induced activation of the Erk and JNK pathways can result in 
Smad phosphorylation and regulate Smad activation. Activation of MAPK pathways 
by TGFβ may also affect transcription responses through direct effects on Smad-
interacting transcription factors, such as the JNK substrate c-Jun or the p38 MAPK 
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substrate ATF-2 (activating transcription factor 2), allowing convergence of TGFβ-
induced Smad and MAPK pathways. 
 
IL-10 and the JAK/STAT system – translating cytokines production in a 
transcriptional program 
IL-10, which was identified by Mosmann and colleagues (Fiorentino et al., 
1989) in 1989, is the founding member of the class II family of α-helical cytokines 
that is composed of the type I interferons, interferon γ and interleukin 10. It is 
produced by various leukocytes. It is expressed by cells of the innate and the 
adaptive immune system, including dendritic cells (DCs), macrophages, mast cells, 
natural killer (NK) cells, eosinophils, neutrophils, CD4 and CD8 T cells, and B cells 
(Pulendran, 2005). IL-10 production can be triggered in vitro in monocytes, 
macrophages and DCs by stimulation with certain PRR ligands, in particular TLRs 
(Boonstra et al., 2006). TLR2 ligands appear to be particularly potent inducers of IL-
10 production (Agrawal et al., 2003) but also TLR9 and TLR4 ligation trigger IL-10 
production from macrophages and DCs (Boonstra et al., 2006).  
IL-10 is recognized by the IL-10R1/IL-10R2 complex, which primarily 
activates the receptor-associated Janus tyrosine kinases Jak1 and Tyk2, resulting in 
STAT1 and STAT3 activation. The Janus kinase/signal transducers and activators of 
transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used 
to transduce a multitude of signals for development and homeostasis in animals, 
from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling 
mechanism for a wide array of cytokines and growth factors.  
Mechanistically, JAK/STAT signaling is relatively simple, with only a few 
principal components. STATs (signal transducers and activators of transcription) 
comprise a family of seven structurally and functionally related proteins: Stat1, 
Stat2, Stat3, Stat4, Stat5a and Stat5b, Stat6. JAKs (janus kinases) represent a family 
of four non-receptor tyrosine kinases, Jak1, Jak2, Jak3 and Tyk2. Jak1, Jak2 and 
Tyk2 are expressed ubiquitously, whereas the expression of Jak3 is restricted to cells 
of the myeloid and lymphoid lineages (Leonard and O'Shea, 1998). These kinases 
selectively phosphorylate STATs, leading to their activation. Once activated, STATs 
play a critical role in regulating innate and acquired host immune responses.	  STATs 
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transduce signals for the large hematopoietin subfamily of cytokines, and the 
conserved family of the receptors they bind. This includes the interferon (IFN)	  
family (IFNα/β, IFNγ, IL-10, IL-19, IL-20, IL-22), the gp 130 family (IL-6, IL-11, 
OSM, LIF, CT-1, IL-12, IL-23, Leptin, CTNF, NNT-1/BSF-3), the γC family, (IL-2, 
IL-4, IL-7, IL-9, IL-15, IL-21) and the single chain family (Epo, GH, PRL, Tpo) of 
the receptors (Schindler and Strehlow, 2000).  
Signaling through the JAK/STAT pathway is initiated when a cytokine binds 
to its corresponding receptor. This leads to conformational changes in the 
cytoplasmic portion of the receptor, initiating activation of receptor associated 
members of the JAK family of kinases. Upon ligand stimulation, receptors undergo 
the conformational changes that bring JAKs into proximity of each other, enabling 
activation by trans-phosphorylation (Remy et al., 1999). Phosphorylated JAKs 
tyrosine kinase domain allow recruitment and association with STATs and other 
signaling molecules. 
Once recruited to the receptor, STATs also become phosphorylated by JAKs, 
on a single tyrosine residue. Activated STATs dissociate from the receptor, dimerize, 
translocate to the nucleus and start their transcriptional program. 
Recent studies have determined that STAT signals are downregulated at 
several points in the signaling cascade including the receptors, JAKs and the STAT 
molecules themselves. Generation of soluble receptors, which compete for limiting 
quantities of ligands, were observed. These isoforms are generated either by 
proteolysis or alternate RNA splicing. Ubiquitin-proteosome dependent degradation 
may also play a role in the downregulation of cytokine signaling. Moreover, JAK 
activation is dependent on tyrosine phosphorylation. It is, therefore, not surprising 
that two related SH2 containing phosphatases, SHP1 and SHP2, have been found to 
negatively regulate JAK activity. Finally, JAK/STAT system activates a negative 
feedback loop through the suppressors of cytokine signaling (SOCS), a family of 
STAT target genes that directly antagonize STAT activation (Kile et al., 2001). 
While the IL-10R2 chain is ubiquitously expressed, IL-10R1 chain is mainly 
expressed on leukocytes. Thus IL-10 acts primarily on leukocytes. IL-10 is a major 
regulator of innate immunity (Mege et al., 2006). It interferes with the production of 
inflammatory mediators by polymorphonuclear neutrophils, monocytes, and 
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macrophages as well as upregulating the expression of molecules that amplify the 
anti-inflammatory effect of IL-10 itself (Moore et al., 2001). IL-10 is a general 
suppressive cytokine. It inhibits pro-inflammatory responses from innate and 
adaptive immunity, and it prevents the lesions in tissues caused by exacerbated 
adaptive immune responses. IL-10 is thus a central cytokine during the resolution 
phase of inflammation. 
All the major TLR signaling pathways (such as those involving NF-κB, p38, 
ERK, and PI-3K) are implicated as the targets for suppression by IL-10, except for 
the JNK pathway downstream of TLR4 signaling (Williams et al., 2004). Moreover, 
it seems that several mechanisms are involved in suppressing different genes and 
even the same gene (Williams et al., 2004). For example, IL-10 was demonstrated to 
inhibit TNFα mRNA and protein expression induced by TLR stimulation via SOCS3 
during the early phase of its signaling, but later it may use Bcl-3 (upregulated by IL-
10 in a STAT3-dependent manner), which interacts with NF-κB at the TNFα 
promoter, to antagonize the formation of functional NF-κBp50/p65 heterodimers and 
thus to inhibit TNFα transcription (Kuwata et al., 2003; Qasimi et al., 2006). 
Consistently with in vitro datas, blocking the IL-10 pathway in mice causes 
spontaneous development of inflammatory bowel disease (IBD). However, 
evolutionarily pathogens have exploited the functions of IL-10 to repress the normal 
host inflammatory responses during infections, thus establishing chronic infectious 
states. Increased IL-10 expression has been associated with many chronic bacterial 
and viral infections. Furthermore, some viruses can produce their own version of IL-
10 (vIL-10) to directly suppress the immune responses of the host (Moore et al., 
1990). The induction of IL-10 in DCs and macrophages represents a powerful 
mechanism of immune evasion used by various pathogens. 
Blocking or enhancing IL-10 efficacy can thus be considered a therapeutic 
approach for the treatment of different kinds of infections. 	  
Glucocorticoids – systemic master tuners of inflammation 
Central nervous system-released hormones and glucocorticoids (GCs) in 
particular are essential in limiting and resolving the inflammatory process (Webster 
et al., 2002). The hypothalamic-pituitary-adrenal axis plays a central role in 
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regulating signaling through the glucocorticoid receptor, which is expressed in 
virtually all cells. Briefly, acute inflammation signals converge at hypothalamus, 
where periventricular nucleus controls the secretion of corticotropin-releasing 
hormone (CRH) into the hypophyseal portal system (Webster et al., 2002). In turn, 
CRH stimulates anterior pituitary gland in releasing corticotropin, that induces the 
synthesis and secretion of cortisol by the adrenal cortex. 
In many ways, glucocorticoids lead to termination of inflammation by 
enhancing the clearance of foreign antigens, toxins, microorganisms, and dead cells. 
They do so by enhancing opsonization and the activity of scavenger systems, and by 
stimulating macrophage phagocytotic ability and antigen uptake (Liu et al., 1999). 
Glucocorticoids stimulate the expression of the mannose receptor (MRC1) or the 
scavenger receptor CD163, promoting clearance of microorganisms, dead cell bodies 
and antigens (Hogger et al., 1998; Piemonti et al., 1999). At the same time, they 
prevent inflammation from overshooting by suppressing the synthesis of many 
inflammatory mediators, such as several cytokines and chemokines, prostaglandins, 
leukotrienes, proteolytic enzymes, free oxygen radicals, and nitric oxide 
(Franchimont, 2004).  
A great number of cytokines (including IL-1β, TNFα, IL-6, IL-8, IL-12 and 
IL- 18, etc.) is broadly downregulated by glucocorticoids. Similarly, secretion of 
many chemokines is strongly suppressed, whereas anti-inflammatory cytokines such 
as IL-10 and TGFβ are upregulated by glucocorticoids (Batuman et al., 1995; 
Elenkov et al., 1996). Soluble or decoy receptors, inhibiting or further enhancing the 
inflammatory process, are also regulated by glucocorticoids. For example, the decoy 
receptor IL-1RII, which binds IL-1β without driving any signaling, is enhanced by 
glucocorticoids (Re et al., 1994). These represent several anti-inflammatory 
mechanisms of action of glucocorticoids.  
It has been proposed that ~1% of the genome might be modulated by 
glucocorticoids (Rhen and Cidlowski, 2005). Glucocorticoids-induced transcriptional 
regulation or glucocorticoids-dependent inhibitory mechanisms are mediated by the 
GC receptor (GR), a member of a large family of nuclear hormone receptor 
transcription factors (Rhen and Cidlowski, 2005). Glucocorticoid receptor is 
expressed in virtually all cells. Human GR messenger RNA (mRNA) has alternative 
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splice variants (Lu and Cidlowski, 2004). Whereas exons 2 through 8 are constant 
components of GR mRNA, there are two exon 9 isoforms that can be spliced to 
produce mature mRNA. Splicing of exon 9a produces GRα mRNA, which is 
translated into a protein with a unique sequence of 50 amino acids at its carboxy end. 
The glucocorticoid receptor α isoform binds cortisol, DNA, and other transcription 
factors, thereby modifying transcriptional activity of target genes. Exon 9b produces 
GRβ mRNA, which is translated into a protein with 15 distinct amino acids at its 
carboxy end. Although glucocorticoid receptor β protein forms homodimers that bind 
DNA, it does not bind any ligands examined so far and fails to activate transcription. 
Glucocorticoid receptor β can also form heterodimers with glucocorticoid receptor α 
and interfere with the function of this protein. The relative levels of glucocorticoid 
receptor α and β in a cell influence the cell’s sensitivity to glucocorticoid, with 
higher levels of glucocorticoid receptor β leading to glucocorticoid resistance (Pujols 
et al., 2001). TNFα and IL-1β can selectively up-regulate the levels of glucocorticoid 
receptor β, suggesting its role in inflammation (Webster et al., 2001). 
Alternative translation-initiation sites within exon 2 produce additional 
isoforms of the glucocorticoid receptor (Lu and Cidlowski, 2004). Translation from 
the first methionine codon in GRα and GRβ mRNA produces proteins that consist of 
777 aminoacids (glucocorticoid receptor α-A) and 742 aminoacids (glucocorticoid 
receptor β-A). Translation from a second methionine produces proteins with 751 
aminoacids (glucocorticoid receptor α-B) and 716 aminoacids (glucocorticoid 
receptor β-B), respectively.	   Glucocorticoid receptor α-B has roughly twice the 
biologic activity of glucocorticoid receptor α-A in gene-expression studies in vitro 
(Yudt and Cidlowski, 2001). The finding that the two isoforms are expressed at 
different ratios in various types of cells and tissues also suggests that they may have 
distinct functions in vivo (Lu and Cidlowski, 2005). Moreover, the human 
glucocorticoid receptor has five serine residues that are phosphorylated under 
different conditions by cyclin-dependent kinases and MAP kinases (Ismaili and 
Garabedian, 2004). The glucocorticoid receptor is found primarily in the cytoplasm 
and is inactive when phosphorylated at serine 203, but it actively transcribes DNA 
when phosphorylated at serine 211 (Ismaili and Garabedian, 2004). 
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Unliganded GRs form large heterocomplexes with heat shock protein 90 
(hsp90) and other heat shock proteins. On hormone binding, the hormone-receptor 
complex rapidly undergoes activation, in the course of which the heterocomplex 
dissociates to an activated hormone-receptor complex monomer and translocate in 
the nucleus (Pratt and Toft, 1997). Once there it can positively regulate gene 
expression by dimerizing and binding to palindromic GC response elements (GREs) 
in the promoters of target genes. GR can also interact with other transcription factors 
such as NF-κB and AP-1, impairing their ability to activate gene expression, a 
process known as transrepression. Most importantly, transrepression is both rapid 
and direct (mediated by pre-existing factors). GC can also block indirectly MAPK
 
Figure 5. Mechanisms of action of glucocorticoids in inhibiting inflammation. The efficacy of GC in 
alleviating inflammatory disorders results from the pleiotropic effects of GC on multiple signaling pathways. 
Classically, the powerful activity of GC is explained through 3 levels of action. 1) Direct genomic effects 
(transcription factor activity): GC couple to their receptor (GR) and move to the nucleus as homodimer to bind 
GRE sequences, recruiting both trancription repressors and activators; 2) Indirect genomic effects (transactivation 
or transrepression): GR-GC complex interacts with other transcription factors, such as NF-κB, AP-1, STATs, 
SMAD4 and others, inhibiting or enhancing their activity; 3) Non-genomic effects (post-transcriptional activity 
and direct activity on signaling pathway): these actions do not require de novo protein synthesis and it can be 
explained by a GC-dependent inactivation of signaling cascade adaptors or by their activity in modulating RNA-
binding proteins such as TTP. 
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cascade by transcription induction of MAPK phosphatase 1. GCs-induced MAPK 
phosphatase 1 dephosphorylates and inactivates JNK, thereby inhibiting c-Jun-
mediated transcription, and p38 family members (Abraham et al., 2006). 
Although GR alone has low affinity for sites that diverge from the GRE 
consensus, high affinity binding and transcriptional activation can be restored in the 
presence of multiple sub-optimal GR binding sites such as half GREs (Lechner et al., 
1997) or adjacent binding sites for other transcription factors (Guido et al., 1996).	  
GR has been shown to cooperate with transcription factors of many different classes, 
including the zinc finger transcription factor, stimulatory protein 1 (Sp1), homeobox 
proteins, ets-related proteins, interferon response factors, helix-loop-helix factors, 
members of the CCAAT/enhancer-binding protein (C/EBP), forkhead box (Fox), 
STAT families and even NF-κB itself (Hofmann and Schmitz, 2002). 
In experimental settings GCs are capable of blocking gene expression even if 
added some time after a pro-inflammatory stimulus, whilst inhibitors of transcription 
are ineffective. GCs have long been known to inhibit inflammatory gene expression 
at a post-trancriptional level, via destabilization of mRNA or inhibition of translation 
(Ing, 2005). Targets of such regulation include COX-2, TNFα, interferon, several 
chemokines and others. The majority of these mRNAs have in common the presence 
of adenylate/uridylate-rich elements (AREs) in their 3′ untranslated regions (UTRs). 
GCs may influence pro-inflammatory gene expression by altering the expression of 
AREBPs, by modulating the activity of the signaling pathways that control them, or 
both (Ing, 2005). 	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Figure 6. A schematic representation of described pro and anti-inflammatory pathways 
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Second wave of control: post transcriptional regulation 
 
Signaling pathways described above are commonly activated during acute 
immune response. Transcription factors programme a transcriptome that induces the 
expression of a family of mRNAs encoding proteins involved in a specific immune 
function. Although transcription is an essential first step in the regulation of gene 
expression, it is a complicated process that cannot be rapidly turned off or redirected. 
Long after transcription has ceased, transcribed mRNAs can continue to synthesize 
proteins. Fortunately, the conversion of DNA into mRNA is only the first step in a 
process that directs the expression of the cytokines, chemokines and survival or 
differentiation factors that define immune cell function. The second step, the 
conversion of mRNA into protein, is a highly regulated process that often has a 
dominant role in coordinating the overall immune response (Shaw and Kamen, 
1986). Factors that promote mRNA degradation or inhibit mRNA translation can 
rapidly repress protein expression despite on-going gene transcription. Most post-
transcriptional control mechanisms target the 3′ untranslated region (UTR) of 
mRNAs to repress the expression of the target transcript. In the immune system, 
post-transcriptional dampening of protein expression can actively promote the 
resolution of inflammation to prevent unintended tissue damage (Chen and Shyu, 
1995). In this way, post-transcriptional control mechanisms link the initiation phase 
and the resolution phase of inflammation. 
 
AU-rich regions and ARE-binding proteins 
The AU-rich mRNAs are a class of mRNAs that bear AU-rich elements 
(ARE) in their 3′ untranslated regions (3′UTR). Estimated now to be in the vicinity 
of 10–15% of all transcripts (Halees et al., 2008), the ARE-mRNAs comprise a 
functionally diverse group including inflammatory and immune response, 
transcription, cellular proliferation, RNA metabolism, development, and signaling 
(Bakheet et al., 2006). Many cytokines, chemokines and proinflammatory proteins 
are subject to ARE-mediated decay (AMD) (Stoecklin and Anderson, 2006).  
The basic units of the ARE are pentamers of AUUUA, nonamers of 
UUAUUUAUU, and AU-rich 'clusters' composed of linked pentamers and/or 
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nonamers. AREs have been subcategorized into various classes on the basis of their 
sequence and deadenylation kinetics (Chen and Shyu, 1995). 
The ARE recruits several different ARE-binding proteins (ARE-BPs) that can 
positively or negatively regulate mRNA stability and/or translation. Because many 
ARE-BPs shuttle between the nucleus and the cytoplasm, binding to specific mRNA 
molecules may occur in either compartment and the composition of individual 
messenger ribonucleoproteins may be modified as the transcript moves through the 
cell. Each of these proteins can individually affect the translation and/or decay of 
ARE-containing mRNA molecules: TIA-1, TIAR15, FXR1P16 and CUGBP2 inhibit 
translation; TTP18, BRF1, BRF2 and KSRP20 promote decay; AUF1 either 
promotes or inhibits decay; and HuR inhibits decay and either promotes or inhibits 
translation. HuR has a central location in this model, and it seems to be pivotal in the 
regulation of cytokine production by orchestrating the binding and activity of other 
ARE-BPs. The complexity of these interactions may explain how HuR can both 
stabilize and either promote or inhibit the translation of ARE-containing mRNA 
molecules (Anderson, 2008). 
 
Fine tuning of inflammation exherted by microRNA 
Discovered more than a decade ago, microRNAs (miRNAs) are a new class 
of small molecular regulators, generated as single-stranded non- coding RNAs of 19-
23 nucleotides in length. These mediators regulate gene expression post-
transcriptionally by binding complementary sequences within the 3’ untranslated 
region of their target mRNA and inducing their degradation or translation inhibition 
(El Gazzar and McCall, 2011). More than 700 miRNAs have been identified in 
mammalian cells (miRNA registry at http://microrna.sanger.ac.uk/sequences; 
http://www.targetscan.org/; http://pictar.mdc-berlin.de; http://www.microrna.org/ 
microrna/home.do). 
Consistent with their roles in specifying cells, miRNAs have been implicated 
in regulating a variety of physiological processes, including hematopoietic cell 
growth, development, activation, differentiation and apoptosis. 
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The biogenesis of miRNAs 
MicroRNAs (miRNAs) are very small (∼22 nt) single-stranded non-coding 
RNA (ncRNA) molecules, processed from hairpin precursors of ∼70 nt (pre-
miRNA), that comes from primary transcripts (pri-miRNA). miRNAs have gained 
much interest, as recent genome-wide studies have shown that they are widespread in 
a variety of organisms and are conserved in evolution. In fact, they are now 
considered one of the largest gene families, and a growing number of biological 
processes involving miRNAs are continuously discovered (He and Hannon, 2004). 
miRNAs in animals are found in diverse genomic locations, as exemplified in 
Figure 7. Most miRNAs are encoded in intergenic regions, but there are also many 
miRNAs that are hosted within the introns of pre-mRNAs or encoded within ncRNA 
genes (Rodriguez et al., 2004). Interestingly, it was observed that there are miRNA 
genes, both hosted and non-hosted, which are clustered. Clustered miRNA genes 
may show high similarity in sequence or not, but for sure they are transcribed as 
polycistrons and have similar expression patterns (Bartel, 2004). 
Figure 7. miRNA primary transcripts. 
Pri-miRs contain 5' cap structures as well 
as 3' poly(A) tails. miRNAs can be cate-
gorized into three groups according to 
their genomic locations. a) Exonic miR in 
non-coding transcripts such as an miR-
23a~27a~24-2 cluster, miR-21 and miR-
155. miR-155 was found in a previously 
defined ncRNA gene, bic. b) Intronic miR 
in non-coding transcripts. miR-15a~16-1 
cluster was found in the 4th intron of a 
non-coding RNA gene. c) Intronic miR in 
protein-coding transcripts. miR-106b~93 
~25 cluster is embedded in the thirteenth 
intron of MCM7 transcript.  
 
miRNAs are transcribed as primary hairpin transcripts by RNA polymerase 
II. These transcripts are first 5′ 7-methyl-guanosine (m7G) capped and 3′ polyadeny-
lated before further processing occurs. Primary miRNA (pri-miRNA) transcripts 
containing one or more local hairpins are cleaved by the nuclear RNase III enzyme 
Drosha and its dsRNA-binding partner DGCR8. In Drosophila, however, some 
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intronic miRNA precursors, termed ‘Mitrons’, are processed in the nucleus by the 
usual RNA splicing machinery and not by the Drosha endonuclease (Ruby et al., 
2007). The pre-miRNAs are then actively transported to the cytoplasm by exportin-5 
in a RAS-related nuclear protein-guanosine triphosphate (RAN-GTP)-dependent 
manner and are further processed into 20-22-nucleotide duplexes by the cytoplasmic 
RNase III enzyme Dicer (Lee et al., 2002). One strand is preferentially incorporated 
into ribonucleoprotein (RNP) complexes called micro-RNPs (miRNPs) or miRNA-
induced silencing complexes (miRISCs). The key components of miRNPs are 
proteins of the Argonaute (AGO) family. In mammals, four AGO proteins (AGO1 to 
 
Figure 8. microRNA processing and activity. miR biogenesis includes the production of the primary transcript 
(pri-miR) by RNA polymerase II or III and its cleavage by the microprocessor complex Drosha-DGCR8 (Pasha) 
in the nucleus. The resulting precursor hairpin (pre-miR) is exported from the nucleus by Exportin-5-Ran-GTP. 
In the cytoplasm, the RNase Dicer-containing complex cleaves the pre-miRNA hairpin to its mature form. The 
functional strand of the mature miRNA is loaded together with Argonaute (Ago2) proteins into the RNA-induced 
silencing complex (RISC), where it guides RISC to silence target mRNAs through mRNA cleavage, translational 
repression or deadenylation. 
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AGO4) were described but only AGO2 seems to be functional. Apart from AGOs, 
miRNPs can contain further proteins that function as regulatory factors or effectors 
mediating inhibitory function of miRNPs (Sontheimer, 2005) (Figure 8).  
 
miRNA-mRNA interactions 
Animal miRNAs can repress targets via surprisingly short base-pairing of 6-8 
nt in the 5’ ends of miRNAs (preferentially nucleotides 2–8) with the 3’ untranslated 
region of targets mRNA, inducing its destabilization and/or inhibiting productive 
translation (Fabian et al., 2010). Both transcriptome and proteome studies provide 
experimental evidence that individual miRNAs can directly repress hundreds of 
target genes (Selbach et al., 2008).  
In the case of animal miRNAs, translational repression has been proposed to 
occur in three distinct ways: cleaving of target mRNAs, repressing mRNA 
translation or promoting its degradation (Figure 8). The cleavage of target mRNAs in 
eukaryotes seems an unusual mechanism, as only one case has been observed (Yekta 
et al., 2004). Target mRNAs are usually found in citoplasm in complex with RNPs 
and miRNA function and mechanism of action depend on the particular proteins 
constituting miRISC (Farazi et al., 2008). Notably, depending on environment and 
stimulation that cell received, microRNAs demonstrate both negative and positive 
regulation capacity of particular transcripts. Cell starvation has been recently 
reported to induce microRNA-dependent transcript protection of TLR4 and TNFα 
mRNAs (Tserel et al., 2011; Vasudevan et al., 2007). 
 
microRNAs and the innate immune system 
The first indication that miRNAs regulate the immune response came in 2004 
with a report which showed selective expression of miR-142a, miR-181a and miR-
223 in immune cells (Chen et al., 2004). miRNAs are now known to be involved in 
the regulation of maturation, proliferation, differentiation and activation of immune 
cells of both the innate and adaptive systems. This has emerged from studies that 
revealed selective expression of miR-181a in the thymus and miR-223 in the bone 
marrow and indicated their involvement in the differentiation of pluripotent 
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hematopoietic stem cells (HSCs) into the various blood cells lineages including B 
and T cells. Subsequent reports have identified functions for individual miRNAs 
such as miR-150, miR-181a and miR-17~92 cluster during T and B cell 
differentiation, whereas miR-17~92 and miR-223 are implicated in myeloid 
production. Experimentation has also revealed roles for miRNAs during the 
activation of the innate and acquired immune response. Thus, miR-146a are miR-155 
are thought to be the most important miRNAs in regulation of the acute 
inflammatory response after the recognition of pathogens by the Toll-like receptors 
(TLR), whereas miR-155 and miR-181a are implicated in B and T cell responses 
(Lindsay, 2008). 
 
microRNAs expression and activity after TLRs engagement 
In the last years, several studies demonstrated that microRNAs, exactly like 
every others genes, can be up-regulated or down-modulated by TLR-dependent 
transcription factors or regulators with different kinetics in innate immune cells, with 
a consensus emerging that miR-155 and miR-146a are particularly ubiquitous. Their 
expressions seem NF-κB and AP-1-dependent, with the latter that is particularly 
indispensable for miR-155 (O'Neill et al., 2011). 
Similar to other TLR-responsive genes, it is also important that the induction 
of TLR-responsive miRNAs is negatively regulated by anti-inflammatory molecules. 
For example, recently McCoy and colleagues characterized an IL-10 dependent miR-
155 inhibition (McCoy et al., 2010). Less is known about microRNAs activity 
inhibition, but emerging evidences, in particular in tumours, suggest that the same 
stimulus that induce miRNA over-expression might also induce particular transcripts, 
usually long non-coding RNA (ncRNA), that act as miR “sponge” and because of 
their function are called competitor endogenous RNAs (ceRNAs). They contain 
multiple copies of miR seed regions, becoming suitable for microRNAs binding and 
therefore sequestering them avoiding interaction with target mRNAs (Cesana et al., 
2011; Karreth et al., 2011; Sumazin et al., 2011; Tay et al., 2011). Moreover, some 
proteins have been described as inhibitors of miRNA biogenesis avoiding their 
processing from pri to pre-miR or from pre to mature miR (Winter et al., 2009). 
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TLR signaling control by miRNAs 
As previously described, TLR signaling pathway is a very complex cascade 
of events that includes a great number of molecules: receptors to sensing pathogens, 
at least four different adaptors molecules that induce several signaling cascade that 
collide in NF-κB, AP-1 and other transcription factors activation and gene 
expression.  
This kind of complexity was described as particularly suitable for microRNA-
induced regulation (Inui et al., 2010). miR-dependent protein inhibition is usually not 
more than 20-30% and therefore per se not significative. Contextualizing this small 
inhibition in an elaborate pathway, such as TLRs system, allow us to highlight the 
magnitude of microRNA impact on acute inflammatory contest and, in general, on 
cell biology. 
In the last years, researchers described innumerable negative but also positive 
interaction between transcriptome and micrornaome induced after TLR engagement. 
Here, we will give the example of miR-155 and miR-146a impacts on TLR response. 
 
i. Ying and yang activity of miR-155  
miR-155 has been extensively researched as a cancer-associated miRNA or 
“onco-miR”. However, miR-155 also has significant role in the immune response. 
This was firstly noted in a key paper by Baltimore et al. (Taganov et al., 2006), who 
have observed miR-155 up-regulation as a continual feature of the mammalian 
inflammatory response. The complexity of miR-155-dependent regulation of 
inflammatory responses was soon evident, as Tili and colleagues suggested a miR-
155-induced down-modulation of several proteins involved in LPS cellular response, 
such as FADD, IKKε and RIP-1, in concomitance with TNFα augmented release 
(Tili et al., 2007). As for TNFα, also CXCL8 and IL-6 protein hyper-expression were 
observed after miR-155 over-expression due to its activity on SHIP-1 and SOCS1 
inhibitory proteins, respectively (Bhattacharyya et al., 2011; Lu et al., 2009). 
In parallel, miR-155-dependent negative feedback circuits were observed. 
Firstly, miR-155 appears as a negative regulator of its own production, as it requires 
AP-1 transcription factor to be induced but it directly targets one of the two 
componend of AP-1 heterodimer, c-fos (Gottwein et al., 2007). Moreover, miR-155 
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seems to act on TLR/IL1R inflammatory pathway directly targeting TAB2, 
inhibiting activation of TAK1 and hence NF-κB and MAPK activation (Ceppi et al., 
2009). miR-155-dependent inhibition of TGFβ-induced IL-1β gene transcription 
from monocytes was observed as consequence of direct targeting of Smad2 exherted 
by miR-155 (Louafi et al., 2010). A schematic representation of miR-155 impact on 
inflammation-related signaling pathway is given in Figure 9. 
Both the positive and negative aspects of these control mechanisms implicate 
it as a highly interesting and significant player in downstream inflammatory 
pathways, and further research in this area will elucidate its main role in the immune 
response. The key to solve this enigma meybe come from observations on the kinetic 
of activation of this interesting miR and its interaction with effects of others miR 
(O'Neill et al., 2011). 
The observation that dysregulation of miR-155 can lead to both cancerous 
phenotypes and inflammatory diseases, provides a clear need for miR-155 itself to be 
stringently regulated. A recent finding in this field that the potent anti- inflammatory 
cytokine IL-10 can down-regulate miR-155 is of note here. This study found that IL-
10 suppresses LPS- induced miR-155 in a STAT3-dependent manner, leading to an 
increase in the miR-155 target SHIP1 (McCoy et al., 2010; Quinn and O'Neill, 
2011). 
 
ii. miR-146a inhibition of TLR signaling mediators 
The miR-146 family is composed of two members, miR-146a and miR-146b 
that are located on chromosomes 5 and 10, respectively. In 2006, Taganov and 
colleagues pubblished a milestone paper in which not only they observed a TLR-
induced set of microRNAs, among which miR-146a, in THP-1 monocytic cell lines, 
but they also proposed the first observation of a negative feedback loop involving 
microRNA-146a, induced by TLR4 activation, that in turn down-modulate TRAF6 
and IRAK1 adaptors expression extinguishing TLR4-dependent signaling (Taganov 
et al., 2006 and Figure 9). They firstly introduce the concept of fine-tuning of the 
immune response, and the same group, recently, strenghtened this concept 
pubblishing their observations on miR-146a knock-out mice (Boldin et al., 2011). 
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Subsequent studies confirmed that over-expression of miR-146a in THP-1 
monocytic cell line makes these cells refractory to any TLR stimulation, mimiking 
endotoxin tolerant state and implicating this microRNA in tolerance induction (El 
Gazzar et al., 2011; Nahid et al., 2011).  
The high expression of miR-146a has been shown to be up-regulated in many 
inflammatory diseases such as osteoarthritis and rheumatoid arthritis (RA), the latter 
involving up-regulation following stimulation with inflammatory cytokines such as 
TNFα and IL-1β. Interestingly, a polymorphism in the 3’UTR of the mRNA 
encoding the miR-146a target IRAK1 is associated with a susceptibility to RA 
(Chatzikyriakidou et al., 2010a) and psoriatic arthritis (Chatzikyriakidou et al., 
2010b). 
Another study implicated miR-146a in regulation of type 1 interferon 
responses (Tang et al., 2009). This study again noted that miR-146a was present at 
reduced levels in SLE patients, and further investigation established that this resulted 
in increased IFNα and IFNβ. miR-146a acts as a negative regulator of interferon 
production in PBMCs, a fine-tuner in maintaining homeostasis. 
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Figure 9. miR-155 and miR-146a impact on inflammation-induced signaling cascade.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aim of the study 	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In 1993, Victor Ambros, Rosalind Lee and Rhonda Feinbaum reported a post-
transcriptional regulation exerted by a short RNA product encoded by lin-4 gene on 
LIN-14 protein in C. elegans. Several years passed before a second confirmation of 
this mechanism led to the establishment of miRNAs as a new class of post-
transcriptional regulators, which bind to complementary sequences on target 
messenger RNA transcripts (mRNAs) and induce translational repression or target 
degradation. Nowadays, miRNA have a well recognized key role in several contests, 
from development to pathogenesis of cancer, but their relevance for inflammation is 
still largely unknown. 
 
The inflammatory response is a robust and essential reaction quickly 
triggered by detection of pathogens, endotoxins or, in general, injurious stimuli. 
Uncontrolled inflammation leads to extensive tissue damage and manifestation of 
pathological states like sepsis, autoimmune diseases, metabolic diseases and cancer. 
For this reason, this process is finely regulated by several mechanisms acting both at 
cellular and systemic level, including injury-induced molecules that inhibit ongoing 
inflammatory reaction, such as dominant negative proteins of TLR signaling 
adaptors, or activate anti-inflammatory programs, such as IL-10 or glucocorticoids. 
In this contest, microRNAs biology perfectly matched with the necessity of fine-
regulation of the entire process, and in 2006 Taganov and colleagues reported the 
first observation of miRNA involvement in the control of inflammation describing a 
negative feedback loop exerted by the LPS-responsive miR-146a on TRAF6 and 
IRAK1, two foundamental adaptors in TLR signaling pathway, in the THP-1 
monocytic cell line. The first aim of this work was to confirm this observation in 
human primary cells of the innate immune system, such as monocytes and 
neutrophils, and to eventually uncover other regulatory feedback circuits exerted by 
microRNAs after TLR4 activation. 
 
Anti-inflammatory stimuli, such as IL-10 or glucocorticoids, are known to 
induce post-transcriptional regulation of pro-inflammatory molecules, such as TNFα 
and IL-6, by means of the activation of tristetraprolin proteins, which bind AU-rich 
elements in the 3’ untranslated region of target transcripts and promote their decay. 
	   55	  
The second aim of our study was to investigate whether the anti-inflammatory 
autocrine/paracrine activity of IL-10 or systemic activity of glucocorticoids also 
included a microRNA-dependent regulation of the pro-inflammatory cascade. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and methods 
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Materials  
Ultra Pure E. coli lipopolysaccharide (LPS, 0111:B4 strain), palmitoyl-3-
cysteine-serine-lysine-4 (Pam3CSK4), and polyinosinic:polycytidylic acids 
(poly(I:C)) were purchased from Invivogen. TNFα, IL-1β, and TGFβ were from 
Peprotech, IL-10 and IFNγ from R&D System, IFNβ from Betaferon (Schering) and 
Dexamethasone from Sigma-Aldrich. Monoclonal antibodies against human TNFα 
(B154.2) were a kind gift from Professor Giorgio Trinchieri (Laboratory of 
Experimental Immunology, National Cancer Institute at Frederick, Frederick, MD) 
whereas monoclonal antibodies against human IL-10R come from Biolegends. 
Brefeldin A, MG-132, BAY-117082, pyrrolidine dithiocarbamate (PDTC) were 
purchased from Sigma-Aldrich, Resiquimod (R848), SP-600125, and SB-203580 
from Alexis (Axxora LLC). 
 
Cell purification and culture  
Human PMN and monocytes were separated by centrifugation on Ficoll-
Paque Plus under endotoxin-free conditions from buffy coats of healthy donors. 
PMN (>99.9% pure) and monocytes (>99.8% pure) were obtained by negative 
magnetic selection performed with the EasySep Enrichment Custom Mixture 
(StemCell Technology) for PMN and with MACS Human Monocyte Isolation Kit II 
(Miltenyi Biotec) for monocytes. The purity of both leukocyte populations was 
assessed by flow cytometry. PMN (6 × 106/ml) and monocytes (2 × 106/ml) were 
then resuspended in RPMI medium 1640 (Cambrex) supplemented with 10% low 
endotoxin FBS (Cambrex) and 2 mM L-glutammine (Cambrex), plated and treated as 
described in Results. 
HEK 293T cells were from ATCC (Manassas, VA) and maintained in 
DMEM (Cambrex) containing 100 U/ml penicillin/streptomycin (Cambrex), and 2 
mM L-glutammine (Cambrex), and 10% FBS (Euroclone). THP-1 cells were 
obtained from ATCC and maintained in RPMI 1640 (Cambrex) supplemented with 
100 U/ml penicillin/streptomycin (Cambrex), 2 mM L-glutammine (Cambrex), 5 × 
10-5 M β-mercaptoethanol (Cambrex), and 10% FBS (Euroclone). Infected THP-1 
were cultured for no more that 2 months in the same medium and conditions of wild-
type cells.  
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Quantification of miRNAs expression level  
PMN and monocytes were stimulated with 100 ng/ml LPS for 8 h and the 
RNAfraction that is highly enriched for small RNA species (< 200 bp) was isolated 
by using the mirVana isolation kit (Ambion, Applied Biosystems), according to the 
manufacturer’s protocol. The small RNA fractions were reverse transcribed and the 
analysis of the expression level of 365 miRNA was performed using a TaqMan-
based Low Density Array. One hundred nanograms of the small RNA fraction were 
reverse transcribed using the microRNA multiplex RT primers and the TaqMan 
microRNA reverse transcription kit (both form Applied Biosystems). The reaction 
was incubated for 30 min at 16 °C, 30 min at 42 °C, and 5 min at 85 °C. Each RT 
reaction was diluted to 0.5 ng/µl in the TaqMan Universal PCR Master Mix (No 
AmpErase UNG, Applied Biosystems) and subsequently distributed into the 
preloaded 365-well micro fluidic card of the TaqMan Human microRNA Array 
(Applied Biosystems). The reaction was incubated at 50 °C for 2 min, followed by 
95 °C for 10 min, and then by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. The 
TaqMan PCR reactions were performed on an ABI Prism 7900HT qPCR system 
equipped with a TaqMan Array Upgrade (Applied Biosystems). 
 
Real time RT-PCR (RT-qPCR) 
The expression of miR-9 precursors (pri-miR-9-1, pri-miR-9-2 and pri-miR-
9-3), CROC-4a, CROC-4b, NFKB1, NFKBIZ, IL-6, TNFα, CD206, IL-1β, Serpine1 
and SMAD2 genes was quantified by RT-qPCR. Total RNA from any cell type used 
was purified using Trizol reagent. 1 µg of total RNA samples were reverse 
transcribed by using the high capacity cDNA Reverse Transcription kit (Applied 
Biosystems) according to the manufacturer’s protocol. Genes expression was 
quantified by RT-qPCR performed in duplicate from 20 ng cDNA in the presence of 
the SYBR green PCR Master Mix (Applied Biosystems) and 400 nM of relative 
primer pairs (Table 1). RT-qPCR data were analyzed with SDS 2.2.2 software and 
normalized to the expression of GAPDH (primers are listed Table 1). The expression 
of indicated miRNAs was quantified by RT-qPCR. Briefly, cDNA was sythesized 
from 100 ng of total RNA fraction using individual miRNA-specific RT primers 
contained in the TaqMan microRNA Human Assays according to manifacturer 
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instructions. Each generated cDNA was amplified in duplicate by qPCR with 
sequence-specific primers from the TaqMan microRNA Human Assays together 
with TaqMan Fast Advanced Master Mix (Applied Biosystems). The ubiquitous 
snRNA U6 was chosen as the internal control. Both RT-qPCR analysis were 
conducted using the Applied Biosystems 7900HT Fast Real-Time PCR System. 
Termal cycler conditions were the following: 95 °C for 20 s, 40 cycles of 95 °C for 1 
s and 60 °C for 20 s. 
 
Constructs and lentiviral particles generation 
Expression cassettes encoding miR-9, miR-155, miR-187, entire cluster or 
miR-125a and let-7e alone, and miR-511 were constructed by amplifying from 
genomic DNA from healthy donors the hairpin sequence (primers in Table 2) and 
flanking regions of respective precursors and cloning them into pcDNA3 vector 
using pCR2.1 as subcloning vector and HindIII and XhoI restriction enzymes.  
For reporter assays, the 3’Untranslated Regions were amplified from genomic 
DNA from healthy donors into the psiCHECK vector 2 (Promega). The pCR2.1 
vector (Invitrogen) was used as subcloning vector. Mutated version of the constructs 
were generated by site-directed mutagenesis using the QuikChange II XL Site-
Directed Mutagenesis Kit from Agilent Technologies (USA) in accordance with data 
sheet instructions or without in the case of 3’NFKB1-mut-luc construct. Primers used 
in inserting mutated basis or deleting seed region-forming basis are indicated in 
Table 3. 
To generate lentiviral particles used to overexpress microRNA of interest in 
THP-1 cell line, packaging plasmids from Invitrogen ViraPower Lentiviral 
Expression Systems were used. pRRLSIN.cPPT.PGK-GFP.WPRE (Addgene) 
carrying miRNA hairpin sequence were obtained as described in results. Briefly, 
miRNA cassettes cloned in pcDNA3 vector were subcloned together with eukaryotic 
constitutive Human cytomegalovirus (CMV) promoter in lentiviral multiple cloning 
site oriented tail-to-tail with respect to EGFP expressing cassette. 11,7 µg of 
Lentiviral vector, 5,85 µg pLP1, 2,93 µg pLP2 and 3,52 µg pVSV-g plasmids were 
co-transfected in low passages HEK293T packaging cell line in 10-cm plates using 
Lipofectamine 2000 according to manufacturer’s protocol. The day after, medium 
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was replaced with fresh DMEM with 10% FBS to allow lentiviral particles release in 
fresh medium. After 24 h, the cell free supernatant was collected and ultracentrifuged 
25000 rpm at 4 °C for 2 hours. 1 × 104 THP-1 cells were plated in 96-well in 100 µl 
of complete RPMI 1640 and 20 µL of concentrated lentiviral particles were added to 
the cells. THP-1 infection were assessed by FACS analysis after 1 week.  
 
Luciferase reporter assay  
For the Luciferase Reporter Assay, HEK293T cells were plated in 24-well 
plates in DMEM supplemented with 10% FCS, 2 mM L-glutamine without 
antibiotics to avoid possible interference with lipofectamine 2000 (Invitrogen) action 
used as liposome carrier in cell transfection. 8 × 104 cells were plated in each well 24 
h before transfection. To clarify microRNAs action on indicated 3’UTRs, cells were 
co-transfected with 100 ng of psiCHECK-2 vector together with miRNA precursors 
or miRNA negative control (Ambion, Applied Biosystems) to a final concentration 
of 100 nM. The day after, cells were lysed and both firefly and Renilla luciferase 
activities were determined using the Dual-Glo Luciferase Assay System (Promega). 
The enzymatic activities of both luciferases were quantified using a MultiDetection 
Microplate Reader Synergy 2 luminometer (BioTek). The use of psiCHECK-2 vector 
enables the detection of changes in the expression of the target gene (3’UTR) fused 
to a primary reporter gene (Renilla luciferase, R-luc). The second reporter gene 
(firefly luciferase, Luc) serves as an internal control that allows normalization of R-
luc expression and activity. Results are expressed as mean ± SEM of the ratio 
between Renilla luciferase and firefly control luciferase activities (RLU) adjusted to 
1. Data represented in the bar graphs derive from 3 experiments each one conducted 
in triplicate. 
 
Monocytes transfection 
Freshly purified monocytes (107) were transfected with 5 µg of plasmid DNA 
(pcDNA3 empty vector, pcDNA3-miR-155 or pcDNA3-miR-9) or with the indicated 
amount of miRNA mimic (Ambion, Applied Biosystems), miRCURY LNA miRNA 
Power Inhibitor (Exiqon) or onTARGETplus siRNA (Dharmacon) using the Amaxa 
Nucleofector and the Human Monocyte Nucleofector kit (Amaxa), according to the 
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manufacturer’s protocol and plated in Recovery medium (Amaxa) supplemented 
with 2mMglutamine and 10% FCS, and stimulated 18 h later as indicated or 
harvested 48 h after transfection and total RNA or whole cell extracts were prepared 
as described in the respective sections. 
 
Western blot 
For immunoblot experiments, THP-1 cells or transfected monocytes were 
lysed in Protein Lysis Buffer containing 50 mM Tris-HCl (pH 7.5), 2 mM EDTA, 
100 mM PMSF, 10 µg/mL Aprotinin, 5 µg/mL Leupeptin, 1% Triton X-100 and a 
cocktail of protease inhibitors (cOmplete, EDTA-free Protease Inhibitor Cocktail 
Tablets, Roche Applied Science, Canada). 35 µg of total proteins from each sample 
were electrophorased in denaturing conditions on SDS-PAGE gel at different 
percentage (depending on proteins analyzed) and transferred to nitrocellulose 
membrane (Bio-Rad). NFKB1 and actin were simultaneously detected using anti-
NFKB1 p105/p50 polyclonal Abs (H-119, Santa Cruz Biotechnology) and anti-actin 
polyclonal Abs (Sigma-Aldrich). Detection was carried out with Alexa Fluor-680 
goat anti-rabbit secondary antibody (Molecular Probes, Invitrogen). Blots incubated 
with anti-IκBζ, anti-STAT3 or anti-IκBα were then probed with goat anti-rabbit or 
anti-mouse antibodies conjugated to Alexa Fluor 680 (Molecular Probes, Invitrogen) 
or Irdye 800 (Rockland Immunochemicals) secondary antibodies, respectively. 
Blotted proteins were detected and quantified using the Odyssey infrared imaging 
system (LI-COR Biosciences). Quantification was performed with the analysis 
software provided by the manufacturer. Anti-p38α, anti-phospho-p38α, anti-
phospho-ERK1/2, anti-SMAD2, anti-phospho-SMAD2 and anti-phospho-SMAD3 
were obtained from Cell Signaling. The secondary antibodies were horseradish 
peroxidase-conjugated donkey anti-rabbit IgG secondary antibodies (GE Healthcare 
Bio-Sciences AB). ECL reagents were from Millipore. Luminescence detection and 
analysis were conducted with ChemiDoc XRS (BioRad) and relative densitometry 
analysis of Westerns blots using Image J software program from NIH.  
 
Cytokine detection in cell-free supernatants 
Supernatants were recovered and centrifuged after stimulation and time 
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points indicated in results section. Cytokines and chemokines concentration was 
measured by specific human ELISA kits for TNFα, IL-6, CCL3, CXCL8 and 
CXCL10 (R&D Systems). 
 
FACS analysis 
THP-1 cells were resuspended in PBS containing 1% Bovine Serum Albumin 
(FACS buffer) and were incubated for 45 min in the dark at 4°C with 
Allophycocyanin (APC)-conjugated monoclonal TLR4 (eBioscience, SanDiego, CA, 
USA) or CD14 (Biolegend) antibodies or respective Isotype control. Cells were then 
washed three times with 1 ml of FACS buffer before analysis. 
 
Apoptosis assay 
5 × 105 over night-starved THP-1 cells were plated in 12-well in RPMI with 
or without 1% FBS with or without 10 ng/mL TGFβ. 48 h after stimulation, cells 
were collected and resuspended in Binding Buffer 1X. 5 µL of APC-Annexin-V and 
5 µL of 7-Amino-Actinomycin D were added to the cells and analyzed with FACS 
Canto II. All reagents were obtained from BD Pharmingen. Datas are presented as 
percentage of Annexin V positive and 7-AAD negative cells (apoptotic but not 
necrotic cells). Bar graphs presents data from 3 independent experiments. 
 
Table 1. Primers used in RT-qPCR analysis 
Gene pri-miR-9–1 
Sense primer GGCTGGATTCCCTCTGATAA 
Antisense primer TGCTAGAGCCTAGCCTCATCTT 
Gene pri-miR-9–1/CROC-4a 
Sense primer TTCCAGCTTTGGGAGTCAAG 
Antisense primer TGGCTCTATCGTCCACACG 
Gene pri-miR-9–1/CROC-4b 
Sense primer GGTGCTGGATGTGGCTCTAT 
Antisense primer GGGCTCGATCTTCTCACCT 
Gene pri-miR-9–2 
Sense primer GGAGGTTCAATTAAGGCAATAAGA 
Antisense primer TGACTTCATTGAGTGCTTTCAGTA 
Gene pri-miR-9–3 
Sense primer ACTTTGCCCCAGCTTCAA 
Antisense primer GTCTCGGCCATTGTCTTCA 
Gene 18 s 
Sense primer CTCAACACGGGAAAGGTCAC 
Antisense primer CGCTCCACCAACTAAGAACG 
Gene NFKB1 
Sense primer CCTGAGACAAATGGGCTACAC 
Antisense primer TTTAGGGCTTTGGTTTACACGG 
Gene GAPDH 
Sense primer AACAGCCTCAAGATCATCAGC 
Antisense primer GGATGATGTTCTGGAGAGCC 
Gene NFKBIZ 
Sense primer GAGACAGGGTCTTGCTCTGG  
Antisense primer CCCAGCATTTTGGGAGACTA  
Gene TNFalpha 
Sense primer GCTGCACTTTGGAGTGATCG 
Antisense primer GAGGTACAGGCCCTCTGATG 
Gene IL-6 
Sense primer TACCCCCAGGAGAAGATTCC 
Antisense primer TTTTCTGCCAGTGCCTCTTT 
Gene CD206/MRC1 
Sense primer GGGCAGTGAAAGCTTATGGA 
Antisense primer CCTGTCAGGTATGTTTGCTCA 
Gene IL-1beta 
Sense primer AGTCTGCCCAGTTCCCCAAC 
Antisense primer GTTATATCCTGGCCGCCTTTG 
Gene SERPINE1 
Sense primer AACCCAGCAGCAGATTCAAG 
Antisense primer GGAACAGCCTGAAGAAGTGG 
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Gene SMAD2 
Sense primer CTCCAGGTATCCCATCGAAA 
Antisense primer GTCGGGGCACTAATACTGGA 
 
Table 2. Primers used in generating plasmids 
Plasmid miR-9–1/pcDNA3 
Sense primer TGTCCCTTCCCTCCTACTCC 
Antisense primer ATCCTCTGGTGCTGGTCAGT 
Plasmid miR-155/pcDNA3 
Sense primer CTTTCTCTCTTGCAGGTGGCACAAAC 
Antisense primer AGGTTGAACATCCCAGTGACCAGA 
Plasmid miR-187/pcDNA3 
Sense primer AGCCAAGACTCCTCAGGTCA 
Antisense primer GCTGTGTACGGAGAGACGAA 
Plasmid entire cluster/pcDNA3 
Sense primer ATGAGGAAGGGGCTGAGG 
Antisense primer TCAGAAGTCAGGCCAGCAAT 
Plasmid let-7e/pcDNA3 
Sense primer CTGTCTGTCTGTCGGGTCTG 
Antisense primer GCAGGGACAAGGACAGAAAA 
Plasmid miR-125a/pcDNA3 
Sense primer TGCCTATCTCCATCTCTGACC 
Antisense primer TGGTGGTCAAATGTCATGCT 
Plasmid miR-511/pcDNA3 
Sense primer AGCTGATAATGGGGGAAAGG 
Antisense primer CCCACGTCTCCTCATGTCTT 
Plasmid luc-fos/psiCHECK-2 
Sense primer GGGGGCAGGGAAGGGGAGGCA 
Antisense primer CGCATTCAACTTAAATGCTT 
Plasmid luc-NFKB1/psiCHECK-2 
Sense primer TGCTGACAATTTCCCACACC 
Antisense primer GGTCATCAATTTGCTTTTCC 
Plasmid luc-NFKBIZ/psiCHECK-2 
Sense primer ATCTGCCTGCCTTAGTCT 
Antisense primer ACCATCAGTTTTTCCAATGT 
Plasmid luc-TNFalpha/psiCHECK-2 
Sense primer TTATTACCCCCTCCTTCAGA 
Antisense primer ATTACAGACACAACTCCCCT 
Plasmid luc-TLR4/psiCHECK-2 
Sense primer ATGGAAATTGTTTATTTATGACAACAT 
Antisense primer AGGTCTAGGGTGATTGAAC 
Plasmid luc-CD14/psiCHECK-2 
Sense primer TGGATAACCTGACACTGGA 
Antisense primer ATGAAGAAAGCCTAAGTATG 
Plasmid luc-IL-6/psiCHECK-2 
Sense primer GTCAGAAACCTGTCCACT 
Antisense primer AATATGTATAAGTTAGCCAT 
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Plasmid luc-CCL3/psiCHECK-2 
Sense primer CTGAGCCTTGGGAACAT 
Antisense primer AGAGCATCTTTATTATTTCC 
Plasmid luc-CXCL8/psiCHECK-2 
Sense primer CCAAGAGAATATCCGAACT 
Antisense primer CAAAGAGAATCCCAATAAGC 
 
 
Table 3. Primers used for mutating/deleting miRNA seed regions 
luc-mut-NFKB1/psiCHECK-2 
CCGTGTAAACGTTTGCCCTA 
TAGGGCAAACGTTTACACGG 
luc-mut-NFKBIZ/psiCHECK-2 
GTTTGACCCAGTATGTCTTGTAGTTAGTTATAATCACCTTGTATCT 
AGATACAAGGTGATTATAACTAACTACAAGACATACTGGGTCAAAC 
luc-mut-TNFalpha/miR-187/psiCHECK-2 
GATGTTTCCAGACTTCCTTGAGGAGCCCAGCC 
GGCTGGGCTCCTCAAGGAAGTCTGGAAACATC 
luc-mut-TNFalpha/miR-125a/psiCHECK-2 
TCTGGAATCTGGAGACAGCCTTTGGTTCTGGC 
GCCAGAACCAAAGGCTGTCTCCAGATTCCAGA 
luc-mut-TLR4/miR-125a/psiCHECK-2 
AAGAAAAGGACAATCAGGATGTCATAAATGAAAATAAAAACCACAATGAG 
CTCATTGTGGTTTTTATTTTCATTTATGACATCCTGATTGTCCTTTTCTT 
luc-mut-TLR4/let-7e/psiCHECK-2 
CCATGACAAAGAAAGTCATTTCAACTCTTATCAAGTTGAATAA 
TTATTCAACTTGATAAGAGTTGAAATGACTTTCTTTGTCATGG 
luc-mut-CD14/psiCHECK-2 
CTGCCTTGGCTTCGAGTCCCGTCAGG 
CCTGACGGGACTCGAAGCCAAGGCAG 
luc-mut-IL-6/psiCHECK-2 
CATTTCTTGGAAAGTGTAGGCTCAAATAAATGGCTAACTT 
AAGTTAGCCATTTATTTGAGCCTACACTTTCCAAGAAATG 
luc-mut-CCL3/miR-125a/psiCHECK-2 
AAATGTGTATCGGATGCTTTTGTGGCTGTGATCGG 
CCGATCACAGCCACAAAAGCATCCGATACACATTT 
luc-mut-CCL3/let-7e/psiCHECK-2 
GTGTGACCTCCACAGCTTTCTATGGACTGGTTGT 
ACAACCAGTCCATAGAAAGCTGTGGAGGTCACAC 
luc-mut-CXCL8/miR-125a/psiCHECK-2 
GATGTTTTATTAGATAAATTTCGGGTTTTTAGATTAAAC 
GTTTAATCTAAAAACCCGAAATTTATCTAATAAAACATC 
luc-mut-CXCL8/let-7e/psiCHECK-2 
AAGTATTAGCCACCATCTCACAGTGATGTTGTGAGG 
CCTCACAACATCACTGTGAGATGGTGGCTAATACTT 
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LPS induces up-regulation of several microRNAs in human monocytes and 
neutrophils 
To identify miRNAs potentially involved in the responses of peripheral 
human PMN and monocytes to stimuli of bacterial origin, the miRNA pattern of 
expression was investigated in PMN and monocytes stimulated for 8 h with 100 
ng/ml LPS using a TaqMan-based Low Density Array. As shown in Figure 10A and 
10B, LPS induced an up-regulation of 12 miRNAs in PMN and/or monocytes 
respectively, whereas no miRNA was significantly down-regulated. LPS-induced 
miRNAs identified in the array were evaluated in a time-course analysis by qRT-
PCR (Figure 10C).  
Figure 10. miRNAs induced by LPS in PMN and monocytes. PMN (A) and monocytes (B) were cultured for 8 
h in medium alone or in the presence of 100 ng/ml LPS. The miRNA fraction was purified and changes in 
miRNA expression levels were determined using a micro fluidic card as described in Materials and Methods. 
Results are expressed as arbitrary units on a log scale using RNU44 as reference control. The mean values of 2 
individual experiments performed are shown. Dotted lines represent the 2 and 0.5 boundary values for fold 
induction. In panel C, the time-course analysis of the single miR is shown. PMN and monocytes were cultured for 
the indicated times in medium alone (- -- - PMN, - -- - monocytes) or in the presence of 100 ng/ml LPS (—
— PMN, —— monocytes). miRNA fraction was purified and miR-9, miR-155, miR-132, miR-146a, miR-
146b, miR-187, miR-125a, miR-99b, and let-7e expression was determined by RT-qPCR and normalized to the 
let-7a levels, as described in Materials and Methods. The results are expressed as fold change and are 
representative of 3 individual experiments.  
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Consistent with the array data, the expression of miR-155, miR-132, miR-
146a, miR-146b, miR-187, miR-125a, miR-99b, and let-7e rapidly increased in LPS-
treated monocytes but not in PMN (Figure 10C). Interestingly, both 3’-end (miR-9) 
and 5’-end (miR-9*) forms of miR-9 were the only miRNAs consistently induced by 
LPS in both PMN and monocytes, being already detectable after 2 h and steadily 
increasing over the time period assessed (Figure 10C). Conversely, the induction of 
miR-222 and miR-196a observed in the array analysis was not confirmed by RT-
qPCR analysis (not shown). miR-9 was then chosen for a more detailed analysis, 
given that it is the only miRNA up-regulated in response to LPS in both cell types 
and that it has not been previously reported to be involved in the inflammatory 
response.  
 
miR-9 expression is modulated in both monocytes and PMNs: biogenesis and 
regulation 
LPS triggers different patterns of responses in PMN and monocytes, partly 
because of the selective activation of the different MyD88- and TRIF-dependent 
signaling pathways downstream of the pattern-recognition receptor TLR4 (Akira et 
al., 2006). To investigate the requirement of MyD88 and/or TRIF adaptors in the 
induction of miR-9 expression by LPS and to evaluate miR-9 regulation by other 
TLRs, PMN and monocytes were stimulated with Pam3CSK4 (100 ng/ml), a 
synthetic lipoprotein agonist at TLR2 that selectively requires TIRAP/MyD88; 
Resiquimod (R848, 10 mM), a TRL7/8 ligand signaling through MyD88 only; or 
polyinosinic:polycytidylic acid (poly(I:C)) (50 µg/ml), a synthetic mimetic of viral 
double-stranded RNA (dsRNA) that interacts with endosomal TLR3 and utilizes 
TRIF-mediated signaling (Akira et al., 2006). As shown in Figure 11A, activation of 
TLR2 and TLR7/8 resulted in up-regulation of miR-9 expression in both cell types, 
while that of TLR3 was ineffective. Conversely, poly(I:C) readily induced miR-155 
in monocytes (Figure 11B), as previously reported in other cell types (O'Connell et 
al., 2007), demonstrating that the lack of miR-9 induction was not due to a general 
failure of monocytes to activate the TRIF-dependent pathway downstream TLR3. In 
agreement with the lack of TLR3 expression in human PMN (Tamassia et al., 2008), 
poly(I:C) had no effect on miR-9 expression in this cell type (Figure 11A). Taken 
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together, these data suggest that in human phagocytes, activation of the MyD88-
dependent signaling pathway is necessary and sufficient to increase miR-9 
expression in response to LPS and that no additional TRIF-dependent signals are 
required. 
Figure 11. miR-9 is induced by MyD88-
activating pathways. miR-155 is evaluated as 
a control. (A) PMN and monocytes were 
cultured for 8 h with 100 ng/ml LPS, 100 ng/ml 
Pam3CSK4, 10 µM R848 or 50 µg/ml poly(I:C), 
TNFα, 20 ng/ml IL-1β, 1000 U/ml IFNγ, or 
1000 U/ml IFNβ. miRNA fraction was extracted 
and analyzed for miR-9 expression by RT-
qPCR. (B) PMN and monocytes were cultured 
for 8 h with 100 ng/ml LPS, 100 ng/ml 
Pam3CSK4, or 50 µg/ml poly(I:C). miRNA 
fraction was extracted and analyzed for miR-
155 expression by RT-qPCR. miRNA 
expression is depicted as fold change units after 
let-7a normalization. Data show 1 experiment 
representative of 3. (C) Monocytes and PMN 
were pretreated for 30 min with medium (black 
bars), 10 µg/ml anti-TNFα MoAbs (hatched 
bars), or 5 µg/ml brefeldin A (gray bars) before 
stimulation with TNFα or LPS. miRNA fraction 
was ex-tracted after 8 h and analyzed for miR-9 
expression by RT-qPCR. miRNA expression is 
depicted as fold change units after let-7a 
normalization. Data show one experiment 
representative of 3. nd: not determined. 
 
 
 
 
To test whether cytokines involved in the response to bacterial and/or viral 
infection are also effective at inducing miR-9 expression, PMN and monocytes were 
stimulated with TNFα (5 ng/ml), IL-1β (20 ng/ml), IFNγ (1000 U/ml), or IFNβ (1000 
U/ml). The proinflammatory cytokines TNFα and IL-1β increased miR-9 levels in 
both PMN and monocytes, while IFNγ and IFNβ were ineffective (Figure 11A). 
Since miR-9 is up-regulated by both LPS and TNFα, we tested whether TLR4 
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induction of miR-9 required a TNFα autocrine signaling as previously reported for 
miR-155 (O'Connell et al., 2007). Anti TNFα MoAbs completely blocked miR-9 
induction by TNFα, but were ineffective when LPS was used (Figure 11C), 
indicating that TNFα is not involved in the induction of miR-9 by LPS. In addition, 
up-regulation of miR-9 expression was not modified by treatment with Brefeldin A 
before LPS stimulation, ruling out the possible involvement of soluble mediators 
released in response to LPS for miR-9 up-regulation (Figure 11C). Taken together, 
these data candidate miR-9 as a novel miRNA involved in the responses of human 
phagocytes to selected stimuli of bacterial origin or proinflammatory cytokines. 
In both mouse and human genomes, miR-9 can be generated by processing of 
3 different miR-9 primary transcripts encoded by distinct genes (C1orf61 for pri-
miR-9–1, BC036480 for pri-miR-9–2, and CR612213 for pri-miR-9–3, respectively). 
LPS induced a time-dependent increase in pri-miR-9–1 levels and had no effect on 
the other 2 miR-9 primary transcripts, both in PMN and monocytes (Figure 12A). 
The miR-9–1 primary transcript derives from the C1orf61 locus which encodes for 
CROC-4 protein, a transcriptional activator for the c-fos proto-oncogene (Jeffrey et 
al., 2000). An EST database analysis revealed the existence of an internal product of 
the C1orf61 locus. Both transcriptional units (here called CROC-4a and CROC-4b: 
Figure 12B) generate the miR-9–1 precursor and are activated by LPS in PMN and 
monocytes (Figure 12C). Analysis of the C1orf61 locus with the transcription start 
sites predictor SwitchGear software (available at http://genome.ucsc.edu) supports 
the existence of an internal transcriptional unit. Inspection of the genomic sequence 
located 2 kb upstream of the predicted start sites of the 2 transcripts identified 
putative promoter regions with consensus binding sites for known LPS-sensitive 
transcription factors, including NF-κB (Figure 12B). The observation that miR-9 
induction by LPS depends on the activation of the MyD88 pathway and the 
identification of NF-κB consensus binding sites within the 2 putative pri-miR-9–1 
promoters suggested that the miR-9 induction by LPS may result from the 
transcriptional activity of NF-κB. This hypothesis was confirmed by the suppressive 
effect on LPS-dependent miR-9 induction of NF-κB inhibitors (MG- 132, BAY-
117082 and PDTC). In contrast, inhibitors of p38 (SB-203580) and JNK (SP-
600125) were ineffective (Figure 12D). Collectively, these data demonstrate that in 
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PMN and monocytes inflammatory stimuli sustain the NF-κB-dependent 
transactivation of C1orf61 locus and consequent production of pri-miR-9 –1. 
 
Figure 12. LPS up-regulates pri-miR-9–1 in a NF-κB-dependent manner. (A) PMN and monocytes were 
cultured in the presence or absence of LPS for the indicated time; total RNA was extracted and pri-miR-9-1 (—
—), pri-miR-9-2 (——), and pri-miR-9-3(——) were analyzed by RT-qPCR and normalized to the 18S 
RNA as described in Materials and Methods. Results show that only pri-miR-9-1, but not pri-miR-9-2 or pri-
miR-9-3, was induced by LPS. (B) Schematic representation of premiR-9-1 genomic locus on intron 3 of the 
CROC-4-encoding gene. The CROC-4a and CROC-4b transcriptional units, the putative transcription factor 
binding sites, and the PCR products identifying the products of the 2 transcriptional units (oligonucleotides are 
shown as thick and amplicons as thin lines) are shown. (C) PMN (Left) and monocytes (Right) were cultured in 
the presence or absence of 100 ng/ml LPS for indicated time, total RNA was extracted, and CROC-4a (——) 
and CROC-4b (——) were analyzed by RT-qPCR in triplicate samples and normalized to the 18S RNA as 
described in Materials and Methods. Results show that both CROC-4a and CROC-4b were induced by LPS in 
both cell types. Both transcripts did not change expression levels in the absence of LPS (dotted lines). (D) PMN 
and monocytes were pretreated for 30 min with medium, 10 µM MG-132, 10 µM BAY-117082, 300 µM PDTC, 
20 µM SP-600125, or 10 µM SB-203580 and subsequently cultured for 8 h with or without LPS. miR-9 
expression levels were determined by RT-qPCR and expressed as fold change after let-7a normalization. Data 
show 1 experiment representative of at least 2 for each panel. 
 
miR-9 affects NFKB1 production during inflammatory response 
To gain insight on the biological relevance of miR-9 induction under 
inflammatory conditions, we searched for predicted miR-9 targets, focusing our 
attention on regulators of transcription, which have been frequently shown to be 
preferential miRNA targets (Asirvatham et al., 2008). In agreement with this, the 
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public database of animal miRNA miRGen (available at http://www.diana. 
pcbi.upenn.edu/miRGen/v3/miRGen.html), which integrates analysis from PicTar 
(Krek et al., 2005), MiRanda (John et al., 2004), and TargetScan (Lewis et al., 2003), 
predicted among high score miR-9 targets the transcriptional regulators Onecut2 and 
PRDM1/Blimp-1, which have been previously validated as miR-9 targets but are not 
expressed in PMN and monocytes (data not shown). A miR-9 seed was also 
predicted in one of few highly conserved regions present in the 3’-UTR of the 
NFKB1 gene. Interestingly, the potential regulatory loop between NF-κB and miR-9 
was also confirmed by the miPromotor software (http://wiki.binf.ku.dk/MiTools). 
Thus, to test whether miR-9 post-transcriptionally affects NFKB1, reporter construct 
containing the renilla luciferase gene fused to the NFKB1 3’-UTR (luc-NFKB1) was 
transiently transfected in HEK-293 cells together with expression plasmids encoding 
miR-9. As shown in Figure 13, miR-9 significantly reduced luc-NFKB1 luciferase 
activity, and the introduction of point mutations in the miR-9 seed in the 3’-UTR of 
NFKB1 (luc-mut-NFKB1) reverted the inhibitory activity of miR-9, demonstrating 
that the NFKB1 3’-UTR contains an active seed of miR-9. The specificity of miR-9 
was also demonstrated by the lack of effect on a c-fos 3’-UTR reporter construct 
(luc-fos), which does not contain a miR-9 seed. Conversely, the c-fos 3’-UTR 
presents a miR-155 seed and was significantly inhibited by miR-155, in agreement 
with previous reports (Gottwein et al., 2007) (Figure 13). 
Figure 13. The NFKB1 gene is a molecular target of miR-9. 
The indicated luciferase constructs (luc vectors) were 
cotransfected with expression vectors encoding miR-155 (gray 
columns), miR-9 (black columns), or the pcDNA3 empty 
vector (white columns). Results are expressed as mean (± SD, 
n = 3) of the ratio between renilla luciferase and firefly control 
luciferase activities (RLU), adjusted to 1. **: P < 0.01; ns: P > 
0.05. 
 
Finally, we analyzed the expression profile of NFKB1 in monocytes 
stimulated with LPS at the transcript and protein levels (Figure 14A and 14B). 
Interestingly, LPS rapidly induced a consistent increase in NFKB1 transcripts 
(Figure 14A), but the transcript up-regulation was not paralleled by a comparable 
increase of the corresponding protein, which showed constant expression levels 
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(Figure 14B). These results indicate that NFKB1 is subjected to a LPS-dependent 
regulation at the transcriptional level and suggest that a second regulatory 
mechanism, acting at the post-transcriptional level, is also operative. In agreement 
with this finding, monocytes over-expressing miR-9 showed a reduced expression of 
the endogenous NFKB1/p105 protein (Figure 14C). Conversely, transfection of 
monocytes with either the pcDNA3 empty vector or with the miR-155-encoding 
vector did not alter the levels of expression of the endogenous NFKB1/p105 protein 
(Figure 14C), confirming the specificity of the effect of miR-9. 
 
Figure 14. Analysis of the endogenous miR-9 target: NFKB1 mRNA and protein expression. (A) monocytes 
were cultured in the presence of LPS for the indicated times. Total RNA was purified and used to assay NFKB1 
mRNA expression by RT-qPCR, as described in Materials and Methods. Relative NFKB1 gene expression is 
depicted as MNE units after GAPDH normalization. Data reported are representative of 3 independent 
experiments. (B) Whole-cell extracts (20 µg) were usually loaded on gels and immunoblots were performed by 
simultaneously using Abs specific for NFKB1 and Abs specific for actin, followed by incubation with Alexa 
Fluor-680 goat anti-rabbit Abs. One experiment representative of 3 is shown. The relative NFKB1/p105 levels 
(±SD, n = 3), quantified as described in Materials and Methods, are reported below each panel. (C) 6 × 106 
monocytes were transfected with 5 µg of pcDNA3 empty vector, miR-155-encoding vector, or miR-9-encoding 
vector as described in Material and Methods. 48 hours posttransfection, 20 µg of were usually loaded on gels and 
NFKB1/p105 protein was detected as described above. The relative NFKB1/p105 levels, normalized for the total 
actin, are reported below the Western blot. One experiment representative of 2 is shown in panel C. 
 
LPS-dependent expression induction of certain miRNAs is sustained by IL-10 
autocrine action on monocytes 
Recently, McCoy CE and colleagues demonstrated that TLR4-dependent 
miR-155 induction in murine macrophages is inhibited by IL-10 stimulation (McCoy 
et al., 2010). Therefore, we decided to perform such analysis in human peripheral 
blood monocytes on the complete panel of microRNAs previously described. As 
shown in Figure 15, IL-10 affected the expression of all the quantified microRNAs in 
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different way: the LPS-mediated over-expression of the well defined “pro-
inflammatory” microRNAs (miR-155, miR-146a and miR-9) was reduced by IL-10 
presence; in contrast, IL-10 induced miR-146b miR-187, miR-125a, let-7e and miR-
99b expression while it strongly potentiated LPS-dependent miR-187, miR-125a, let-
7e and miR-99b induction. Taken together, these data suggest that IL-10 can modify 
microRNA expression profile in monocytes after LPS exposure and point out miR-
187 and miR-99b~7e~125a cluster as LPS-induced miRNAs strongly up-regulated 
by IL-10. 
 
Figure 15. miRNAs induced by LPS/IL-10 in monocytes. A time-course analysis of miRNAs considered are 
shown. Freshly isolated monocytes were cultured for the indicated times in medium alone or in the presence of 
100 ng/ml LPS (−−), 30 ng/ml IL10 (- -- -) or the combination of both stimuli (−− in grey). Total RNA was 
extracted and miR-9, miR-155, miR-146a, miR-146b, miR-125a, miR-99b, let-7e and miR-187 expression was 
determined by RT-qPCR and normalized to the snRNU6 levels, as described in Materials and Methods. The 
results are expressed as fold change respect to the medium condition and are representative of at least 2 
individual experiments.  
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In human monocytes LPS stimulates IL-10 production, which in turn acts on 
monocytes in an autocrine manner (Saraiva and O'Garra, 2010). In order to 
investigate whether endogenously produced IL-10 plays a role in the expression of 
miR-187 and miR-99b~7e~125a cluster induced by LPS, monoclonal anti-IL-10R 
antibody (or isotype-specific control IgG) was added to monocytes, and the 
expression levels of miRs were analyzed 24 h after LPS stimulation (Figure 16). 
Blocking endogenous IL-10 action reduced the induction of miR-187, miR-125a, let-
7e or miR-99b by LPS and significantly increased LPS-induced miR-155 expression 
(Figure 16).  
 
Figure 16. Modulation of IL-10 inuced miRNAs expression by endogenous IL-10. Monocytes were 
pretreated for 30 min with 1 µg/ml anti-IL-10R MoAbs (black bars) or 1 µg/ml Isotype control (white bars) 
before stimulation with 100 ng/ml LPS. Total RNA was extracted after 24 h and analyzed for indicated miRNA 
expression by RT-qPCR. miRNA expression is depicted as fold change respect to unstimulated control units after 
snRNU6 normalization. The results are representative of 2 individual experiments. *: P < 0.05 
 
Mature miR-187 is generated by processing of a precursor (pre-miR-187), 
transcribed from an intronic region located on chromosome 18 (Figure 17A) Mature 
miR-125a, let-7e and miR-99b come from a single transcript located on chromosome 
19 upstream a long non coding RNA transcript (UNQ2487, NR_024330.1) (Figure 
17B). Expression of mature miR-99b~7e~125a cluster and UNQ2487 are induced at 
the same time in our experimental conditions (Figure 17C), suggesting co-
transcription of these RNAs. 
Taken together, these data support a role for endogenous IL-10 in LPS-induced 
miRNAs expression, and, above all, call attention to miR-187 and miR-99b~7e~125a 
cluster as unique miRNAs induced by LPS in an IL-10 dependent manner. 
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Figure 17: miR-99b, let-7e and miR-125a are a product of a unique transcript. Schematic representation of 
pre-miR-187 genomic locus (A) or UNQ2487/cluster miR99b~7e~125a genomic locus (B). Grey bars represent 
exon, triangles are introns, whereas black lines are not-annotated genomic regions. Chromosome in which the 
regions are located are indicated on the left. (C) Monocytes were cultured for 24 h in the presence of 100 ng/ml 
LPS alone (white bars) or in combination with 30 ng/ml IL-10 (black bars). Results are showh as fold change 
respect to untreated cells after normalization to the snRNU6 levels. Datas are representative of 2 experiments. 
 
Over-expression of IL-10-induced microRNAs in a human monocytic cell line 
impairs cell response to LPS 
MicroRNAs are key regulators of gene expression. Despite great advances, 
the miRNA world remains largely not explored and discovering the function of a 
single microRNA is challenging. First, each miRNA has numerous putative targets 
that have disparate functions (Lewis et al., 2003), with no means to decide a priori 
which one is most meaningful. Second, the degree of target down-regulation 
imposed by miRNAs often tends to be quantitatively modest: measured at the protein 
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level, an over-expressed miRNA usually inhibits most of its endogenous targets by 
less than 50% (Thomas et al., 2010).  
In a recently published review, Inui Masafumi and colleagues showed that 
signal transduction pathways are prime candidates for miRNA-mediated regulation 
in animal cells. They assessed that signaling cascade are highly dynamic and non-
stoichiometric molecular ensembles, which translate into well established dose-
dependent responses. As such, they are the ideal targets for the degree of quantitative 
fluctuations imposed by miRNAs. This might enable the multi-gene regulatory 
capacity of miRNAs to remodel the signaling landscape, both in a positive and in a 
negative way (Inui et al., 2010). 
 
Figure 18: TLR signaling molecules affected by miR-187 and entire cluster. A list of molecules recognized 
by TargetScan software as targets of miR-187, miR-99b, let-7e and miR-125a was integrated with IPA “canonical 
pathway” informations. A schematic representation of Toll-like Receptor Signaling pathway is reported. The 
direct putative targets of analyzed microRNAs are highlighted here in red.  
 
To visually underline the impact of LPS-dependent IL-10-potentiated 
expression of miR-187 and miR-99b~7e~125a cluster in LPS-driven signaling 
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cascade, we took advantage of two prediction software: TargetScan, a widely used 
on-line software predicting microRNA’s target mRNAs, and Ingenuity Pathway 
software (IPA), that models conventional signaling pathway starting from a list of 
apparently random molecules. Integrating the list of all miR-187, miR-99b, let-7e 
and miR-125a targets generated by TargetScan with pathway information produced 
by the IPA software, we observed that TLR signaling pathway is one of the most 
affected by the concomitant expression of these microRNAs (Figure 18).  
To confirm the in silico prediction, an in vitro cellular model was produced 
over-expressing microRNAs of interest (miR-187 and miR-99b~7e~125a cluster) or 
a scramble sequence as a control in THP-1 cells, a human monocytic cell line, 
 
Figure 19: THP-1 infection with lentiviral particles induce a strong up-regulation in miR cloned in plasmid 
constructs together with EGFP protein expression. (A) A schematic representation of lentiviral plasmid 
construction is here reported. Briefly, 300-600 bp-long region including pre-miR sequence was cloned in 
pcDNA3 empty vector. miR-expressing region was then subcloned in lentiviral vector plasmid together with 
CMV promoter (coming from pcDNA3 plasmid) in tail-to-tail orientation respect to EGFP ORF. (B) Total RNA 
was extracted from THP-1 infected with lentiviral particle carrying entire cluster region cloned vector, miR-187 
region cloned vector or scramble region cloned vector (as indicated in the bar graph). RNAs were retrotranscribed 
and analyzed for miR-125a (left panel) or miR-187 (right panel) expression by RT-qPCR. miRNA expression is 
reported as 2-ΔCt normalized to snRNU44 levels. (C) A FACS analysis of infected THP-1 versus not-infected 
THP-1 (THP-1 wild-type) is here reported.  
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through lentiviral infection. The genomic sequences in which miR-187 or miR-
99b~7e~125a cluster are located were cloned (459 base-pairs or 842 base-paires, 
respectively) in pcDNA3, a vector with a multiple cloning site downstream CMV 
eukaryotic constitutive promoter. This promoter region together with pre-miR 
sequences were then subcloned in the lentiviral vector pRRLSIN.cPPT.PGK-
GFP.WPRE (Addgene) that, per se, induces constitutive expression of EGFP protein 
gene, labelling infected cells with green fluorescent protein (Figure 19A). Lentiviral 
particles produced with these vectors (as indicated in “material and methods” issue) 
drives integration of pre-miRs sequences downstream the CMV promoter in THP-1 
genome, leading to microRNA (or control sequence) constitutive over-expression 
together with EGFP production (Figure 19B). 
 
Figure 20: Global impairment in pro-inflammatory cytokines and chemokines production in THP-1 
infected cell line. THP-1 overexpressing miR-187, entire cluster or a scramble sequence were seeded and 
stimulated with 1 µg/µL LPS (TLR4 agonist) or 1 µg/µL Pam3CSK4 (TLR2 agonist). Supernatants were collected 
and analyzed by ELISA assay at indicated time points except for IL-6 measurements (panel B) that was carried 
only after 24 h. Dotted lines or withe bars indicate scramble-THP-1 production of indicated cytokine/chemokine, 
whereas black lines or bars indicate miR-187 or cluster-THP-1 (as indicated on the left) production. Every 
experiment was carryed in duplicated. Datas show one of at least 2 individual experiments. 
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Over-expressing cell lines were therefore exposed to different stimuli to 
assess their ability in inducing a proinflammatory signaling cascade. Keeping in 
mind the in silico predicted impact of these microRNAs on TLRs pathway, we 
performed THP-1 stimulation with LPS and Pam3CSK4, specific TLR4 and TLR2 
agonists respectively. Several pro-inflammatory mediators were measured at 
different time points till 24 h except for IL-6, whose production remains undetectable 
at early time points. As shown in Figure 20, a general impairment in producing 
cytokines and chemokines were observed both in THP-1-187 and in THP-1-cluster 
compared with controls. In particular, TLR4-dependent pathway appeared to be more 
regulated than TLR2-dependent cascade. Indeed, TLR4 lost almost 50% of its 
capacity in inducing pro-inflammatory molecules production, whereas both miR-187 
and cluster over-expressing cells showed less impairment in TLR2 agonist-induced 
cytokines and chemokines production. 
Among all these microRNAs, ability of let-7e in reducing TLR4 receptor 
expression and therefore signaling cascade activation has already been described in 
murine macrophages (Androulidaki et al., 2009). Moreover, in silico analysis of 
microRNA-99b targets alone revealed very few molecules related to inflammation 
(data not shown). We therefore decided to use THP-1 cells over-expressing miR-187, 
miR-125a or let-7e alone to better characterize their modality in inducing TLRs 
desensitization. To this aim, we took advantage of THP-1 ability in producing 
CXCL10 in response to several stimuli. Stimulations with TLR4 or TLR2 agonists 
and IFNγ were performed and CXCL10 production levels in cell free supernatants 
were measured by ELISA. As shown in Figure 21, TLR4 and TLR2-dependent 
CXCL10 production were severely impaired in THP-1 over-expressing miR-187 and 
miR-125a compared to the control, whereas let-7e affected only TLR4-dependent 
response, confirming the ability of let-7e in modulating TLR4 receptor expression 
previously observed by Androulidaki A and colleagues (Androulidaki et al., 2009). 
IFNγ exposure led to the same produced CXCL10 amount in all cell types analyzed. 
Therefore, miR-187 and miR-99b~7e~125a cluster activity were analyzed 
independently. 
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Figure 21: miR-187 or cluster-dependent inhibition of TLR4 or TLR2 pathway. THP-1 overexpressing miR-
187, entire cluster or a scramble sequence were seeded and stimulated with 1 µg/µL LPS (TLR4), 1 µg/µL 
Pam3CSK4 (TLR2) or 100 ng/µL IFNγ. CXCL10 production level of THP-1 overexpressing scramble sequence 
(white bars) or indicated miRs (black bars) are here reported. Every experiment was carryed in duplicated. Datas 
show one of at least 2 individual experiments. 
 
miR-187 inhibits IkBζ  expression 
Among the potential targets predicted by TargetScan used to performed the in 
silico analysis schematically represented in Figure 18, we focused our attention on 
inflammation-related transcription factor-encoding genes, as identified by GO-terms 
association, that have been frequently shown to be preferential miRNA targets 
(Asirvatham et al., 2008). This analysis indicated a potentially favourable interaction 
between the miR-187 and one 7mer site in the 3’UTR region of the transcriptional 
activator NFKBIZ transcript. Additional data indirectly supported the prediction of 
NFKBIZ as one of miR-187 target genes. In fact, the kinetic of expression of the 
NFKBIZ gene product, the IkBζ protein, inversely correlates with the expression of 
miR-187 in monocytes stimulated with LPS (Figure 22). This inverse correlation is 
even stronger in monocytes stimulated with LPS plus IL-10, in which miR-187 
expression is potentiated, whereas the expression of IkBζ is further reduced, 
particularly at 12 and 24 h when this effect is the most pronounced. Luciferase assay 
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was utilized to confirm the predicted interaction of miR-187 with the 3’UTR of 
NFKBIZ transcript (Figure 23A). Luciferase activity is reduced by ~ 30% in 
HEK293 cells transfected with a luciferase reporter construct expressing the 
NFKBIZ 3’UTR together with mIR-187 mimic but not with a miR-scramble (miR-
scr) used as control. Point mutation of the miR-187 seed region in the NFKBIZ 
3’UTR abolished miR-187-mediated inhibition of luciferase activity (Figure 23A), 
demonstrating the specificity of miR-187-NFKBIZ 3’UTR interaction. 
Figure 22: IκBζ protein levels down-modulation correlates with miR-187 up-regulation in stimulated 
human monocytes. Monocytes were cultured for the indicated times with LPS alone or in combination with IL-
10. (A) Whole-cell extracts and small RNA fractions were purified in parallel as described in Materials and 
Methods. 100 µg proteins were loaded on gels and immunoblots were performed by using specific anti-IκBζ and 
anti-STAT3 Abs. (B) Quantitative analysis of the expression levels of IκBζ and miR-187. The relative IκBζ 
protein levels, quantified by the Odyssey software and normalized for the total STAT3, are reported as white 
bars, whereas black dots show the expression of miR-187 determined by RT-qPCR on small RNA fractions 
purified from the same samples. One experiment representative of three is shown. 
 
In order to provide direct evidence for NFKBIZ as a physiologic target of 
miR-187, we tested whether miR-187 can directly influence the levels of the 
endogenous IkBζ protein expression (Figure 23B-E). A miR-187 mimic or a 
scramble negative control were transiently transfected in monocytes and the level of 
IkBζ protein expression following LPS stimulation was assessed (Figure 23B). Three 
hours after LPS stimulation, a reduction of the IkBζ protein levels was observed in 
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monocytes over-expressing the miR-187 mimic as compared to monocytes 
transfected with the miR-scr control (Figure 23B and C). In a complementary 
approach, we functionally inhibited miR-187 by transiently transfecting monocytes 
with a specific miR-187 single strand DNA-LNA knockdown probe (as-miR-187) or 
with a scramble miRNA knock-down probe (as-miR-scr) as a control. Reduction of 
miR-187 expression increases IkBζ protein levels in monocytes stimulated for 3 h 
with LPS and LPS plus IL-10, respectively (Figure 23D and 23E).  
Figure 23: NFKBIZ is a predicted miR-187 target gene. (A) HEK 293T cells were cotransfected with the 
indicated luciferase constructs and 100 nM miR-187 mimics or scramble control. Results are expressed as mean 
(±SD, n = 3) of the ratio between renilla luciferase and firefly control luciferase activities (RLU), adjusted to 1. *: 
P < 0.05; ns: P > 0.05. (B) and (D) Total cell extracts (100 µg) were usually loaded on gels and immunoblots 
were performed by simultaneously using Abs specific for IκBζ and STAT3, followed by incubation with Alexa 
Fluor 680 goat anti-rabbit and IRDyeTM 800 goat anti-mouse Abs. One experiment representative of three is 
shown. (C) and (E) The blots were scanned on the Odyssey Infrared Imaging System at 700 nm and 800 nm 
wavelenght. The relative IκBζ levels (±SEM; n = 3), as quantified by the Odyssey software and normalized for 
the total STAT3 are reported (**: P < 0.01; *: P < 0.05). 
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Collectively, these data identify NFKBIZ as an endogenous miR-187 target 
and indicate the induction of miR-187 as one of the mechanisms utilized by IL-10 to 
suppress LPS-induced IkBζ expression. 
 
IL-10-dependent IL-6 down-modulation occurs also through miR-187 activity on 
IκBζ  
In mouse macrophages the nuclear protein IkBζ, also known as MAIL 
(Kitamura et al., 2000), is induced upon TLR/IL-1R stimulation and is required for 
the LPS-dependent induction of IL-6 (Kitamura et al., 2000; Seshadri et al., 2009; 
Yamamoto et al., 2004). We confirmed that human monocytes exposed to LPS up-
regulate IkBζ expression which in turn triggers IL-6 production (Figure 24). A dose-
dependent IkBζ knockdown by specific IkBζ-silencing siRNA (si-IkBζ) leads to a 
decrease in LPS-induced IL-6 production. Conversely, LPS-induced TNFα 
production in si-IkBζ- and si-ctrl-transfected monocytes are comparable (Figure 
24D). 
Figure 24: Knockdown of IκBζ suppresses 
the LPS-induced IL-6 production. Freshly 
purified monocytes were transfected with 
increasing amounts of si-IκBζ siRNA or with 
the same amount of siRNA control. The day 
after, monocytes were stimulated with LPS for 3 
h, supernatants were collected and cells lysed in 
order to extract total RNA and proteins in 
parallel. 100 µg of whole cell extracts were 
analyzed by immunoblotting and the levels of 
IκBζ, IκBα and STAT3 were detected at the 
Odyssey Infrared Imaging System (A). Panel 
(B) show the levels of IκBζ normalized versus 
total STAT3, as detected in one experiment 
representative of three performed. IL-6 and 
TNFα were detected on cell-free supernatants by 
ELISA and the variation in cytokine release 
observed in monocytes transfected with si-IκBζ 
versus si-Ctrl were plottd in panel (C) (mean 
percentage ± SEM, n = 3) 
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To investigate whether the negative regulation of IkBζ by miR-187 was 
functionally involved in the production of IL-6 by LPS and in its regulation by IL-
10, human monocytes were transfected with miR-187 mimic or with si-IkBζ along 
with their relative controls, and the expression of IL-6 was analyzed after 3 h of LPS 
activation (Figure 25). The reduction of IkBζ expression mediated by either miR-187 
or si-IkBζ causes a significant and comparable reduction of the LPS-induced IL-6 
transcription (Figure 25), thus demonstrating that miR-187 reduces IL-6 expression 
by knocking down the expression of its transcriptional activator IkBζ.  
Figure 25: LPS-induced IL-6 gene expression is reduced by miR-187-mediated IκBζ knockdown. 
Monocytes were transfected with 150 pmol miR-scr or miR-187 mimic or  15 pmol si-Ctrl or si-IκBζ siRNA, let 
reover for 18 h, stimulated with LPS for 3 h, and then processed for IL-6 expression analysis. Total RNA was 
purified and the expression of IL-6 mRNA was analyzed by RT-qPCR as described in Materials and Methods. 
IL-6 expression is expressed as fold change after normalization to the GAPDH housekeeping. Means ± SEM are 
reported (n = 5, **: P < 0.01) 
 
We then measured LPS-induced IL-6 production in supernatants of 
monocytes in which the IkBζ level was either knocked down by miR-187 over-
expression or increased by as-miR-187 (Figure 26A-D). LPS-induced IL-6 
production is reduced in monocytes over-expressing miR-187 as compared to 
monocytes transfected with miR-scr (Figure 26A), whereas miR-187 knockdown by 
as-miR-187 results in increased IL-6 production (Figure 26B). Finally, secretion of 
IL-6 by monocytes stimulated with LPS plus IL-10 is also affected by miR-187-
dependent modulation of IkBζ protein level (Figure 26C). LPS-induced IL-10 
production was not modified by any conditions (Fig. 26E-G), thus excluding a role 
for IL-10 in the inhibition and/or increase in LPS-induced IL-6. Collectively, these 
data demonstrate that IL-10, through the miR-187-mediated reduction ok IkBζ, 
indirectly inhibits LPS-induced IL-6 transcription and production. 
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Figure 26: IL-6 production, but not IL-10 production, is affected by overexpression and/or silencing of 
miR-187. Monocytes were transfected with miR-187 mimic or as-miR-187, along with their respective miR-scr 
and as-miR-scr controls, as indicated. IL-6 levels were determined by ELISA in cell-free supernatants collected 
24 h after stimulation with LPS alone (A, B) or with LPS plus IL-10 (C). In parallel, IL-10 levels were quantified 
only after stimulation with LPS alone (E, F). Changes in the levels of IL-6 (D) or IL-10 (G) release by miR-187-
transfected versus mIR-scr-transfected monocytes and as-miR-187 transfected versus as-mIR-scr-transfected 
monocytes are shown (mean % variation ± SEM; n = 5). 
 
miR-187 dampens inflammation through direct interaction with TNFα 3’UTR 
Consistent with observation in macrophages from IkBζ knockout mice 
(Kitamura et al., 2000), the production of LPS-induced TNFα was not significantly 
modified in si-IkBζ-transfected monocytes (Figure 24D). Conversely, a marked 
reduction in TNFα production was observed in response to LPS in human monocytes 
over-expressing the miR-187 mimic, as compared to the miR-scr (Figure 27A and 
27C). To exclude an off-target effect of miR-187 over-expression, we investigated 
whether miR-187 knockdown was affecting TNFα production as well. Monocytes 
transfected with as-miR-187 or with as-miR-scr were stimulated with LPS or LPS 
plus IL-10, and TNFα release was determined in cell free supernatant at 24 h. LPS-
induced TNFα production was only slightly, but not significantly, affected by miR-
187 knockdown (not shown). On the contrary, blocking miR-187 expression give 
rise to a significantly higher TNFα release in response to LPS plus IL-10 (Figure 
27B and 27C). Taken together, these data point to TNFα as an additional miR-187 
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target. Indeed, a miR-187 seed was predicted in the 3’UTR of the TNFα transcript by 
both Miranda and TargetScan algorithms. To confirm TNFα mRNA as a direct target 
of miR-187, a reporter construct containing the Renilla luciferase gene fused to the 
TNFα 3’UTR (luc-TNFα) was transiently transfected into HEK293 cells together 
with miR-187 mimic or miR-scr. As shown in Figure 27D, miR-187 significantly 
reduced luc-TNFα luciferase activity, and the introduction of point mutations in the 
miR-187 seed in the TNFα 3’UTR (luc-mut-TNFα) reverted the inhibitory activity of 
miR-187, demonstrating that TNFα 3’UTR contains an active seed of miR-187. 
Collectively, these data demonstrate that miR-187 is part of the IL-10 dependent 
post-transcriptional control of TNFα. 
 
Figure 27: TNFα is a direct target of miR-187. The amount of TNFα was quantified by ELISA in cell-free 
supernatants collected after 24 h from monocytes transfected with miR-187 mimics or miR-scr and stimulated 
with LPS (A) or transfected with as-miR-187 or as-miRscr and stimulated with LPS plus IL10 (B). (C) Percent 
variation of TNFα released by monocytes transfected with miR-187 mimic or as-miR-187 versus their respective 
controls is shown (mean ± SEM, n = 5). (D) HEK 293T cells were cotransfected with the indicated luciferase 
constructs and 100 nM miR-187 mimics or scramble control. Results are expressed as mean (±SD, n = 3) of the 
ratio between renilla luciferase and firefly control luciferase activities (RLU), adjusted to 1. *: P < 0.05; ns: P > 
0.05. 
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miR-99b~7e~125a cluster modulate cytokines and chemokines release in response 
to LPS 
In parallel, we analyzed the activity of miR-99b~7e~125a cluster on TLR 
signaling, among receptor proteins or effector molecules. Analyzing the 3’UTR of 
TLR4, TLR2 or their co-receptors, we identified several seed regions recognized by 
cluster members in both TLR4 and CD14, a TLR4 signaling partner protein involved 
in recognizing pathogen-derived molecules that has been demonstrated as 
fundamental in TLR4-dependent signaling transduction (Ostuni et al., 2010). 
Luciferase assays were performed to assess the activity of miR-125a and let-
7e on TLR4 3’UTR, cotrasfecting miR-125a mimic, let-7e mimic or the scramble 
 
Figure 28: TLR4 recepor is a direct target of miR-125a. (A) HEK 293T cells were cotransfected with the 
indicated luciferase constructs and 100 nM miR-125a or let-7e mimics or scramble control. Results are expressed 
as mean (±SD, n = 3) of the ratio between renilla luciferase and firefly control luciferase activities (RLU), 
adjusted to 1. *: P < 0.05; ns: P > 0.05. (B) FACS analysis indicative of three indipendent experiments of THP-1 
overexpressing miR-125a or a scramble sequence after staining with APC-conjugated anti-hTLR4 Abs is here 
reported. (C) Mean of the fluorescence intensity subctracted of the isotypic control obtained in three experiments 
is shown in the bar graph. *: P < 0.05; ns: P > 0.05. 
 
control together with a reporter construct expressing Renilla luciferase coding 
sequence fused with TLR4 3’UTR in HEK293 cell line. Over-expression of miR-
125a or let-7e inhibits luciferase expression as compared to the control. This 
inhibition was restored by mutating miR-125a or let-7e seed region respectively, 
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demonstrating the specificity of the observed down-modulation. These results 
confirm what has been already shown about let-7e ability in TLR4 regulation 
((Androulidaki et al., 2009) and Figure 28C). To go deep in demonstrating the in 
silico-predicted and with luciferase assay validated miR-125a activity, TLR4 protein 
expression on miR-125a over-expressing THP-1 cells surface were investigated. As 
shown in Figure 28B and C, TLR4 translation was inhibited in miR-125a over-
expressing THP-1 as compared with the control. 
The same experiments were performed to assess the CD14 post-translational 
inhibition operated by miR-125a. As shown in Figure 29A, luciferase assay sustained 
the hypothesis of miR-125a activity on both TLR4 and its co-receptor CD14 3’UTR, 
inhibiting the Renilla luciferase – wild-type 3’UTR CD14 fused construct expression 
but not its mutated counterpart when cotrasfected together with miR-125a mimic. 
The same reduction amount was observed also at protein level, reducing CD14 
receptor detection through FACS analysis on membrane of THP-1 over-expressing 
miR-125a as compared to control cells (Figure 29B).  
 
Figure 29: CD14 co-receptor protein is a miR-125a target gene. (A) HEK 293T cells were cotransfected with 
the indicated luciferase constructs and 100 nM miR-125a mimics or scramble control. Results are expressed as 
mean (±SD, n = 3) of the ratio between renilla luciferase and firefly control luciferase activities (RLU), adjusted 
to 1. *: P < 0.05; ns: P > 0.05. (B) FACS analysis indicative of three indipendent experiments of THP-1 
overexpressing miR-125a or a scramble sequence after staining with APC-conjugated anti-hTLR4 Abs is here 
reported. (C) Mean of the fluorescence intensity subctracted of the isotypic control obtained in three experiments 
is shown in the bar graph. *: P < 0.05; ns: P > 0.05. 
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These results are consistent with the global impairment in TLR4 response 
observed in Figure 20 and 21 and suggest that miR-125a exerts post-transcriptional 
inhibition on both TLR4 receptor and its coreceptor CD14 by direct targeting their 
3’UTR, leading to down-modulation of protein expression on monocytes surface and 
negative regulation of cell response to pathogens. In contrary, these data can not 
explain the impairment observed in TLR2-dependent cytokines and chemokines 
production. 
To this aim, an in silico analysis of 3’UTR of all the cytokines and 
chemokine tested by ELISA (Figure 20 and 21) were conducted. Surprisingly, we 
found at least one seed region of cluster’s microRNAs in every pro-inflammatory 
mediator tested, apart from CXCL10. We therefore decide to clone their 3’-
untranslated regions and fuse each of them with Renilla luciferase gene in order to 
test miR-125a and let-7e ability in reducing luciferase expression and activity. As 
 
Figure 30: miR-125a and let-7e show a unique capacity in downmodulating several cytokines and 
chemokines mRNA. In panel (A) different combinations of target-miR luciferase reporter assays are shown. 
Indicated construct were cotransfected with 100 nM of indicated miR mimics or scramble control. Results are 
expressed as mean (±SD, n = 3) of the ratio between renilla luciferase and firefly control luciferase activities 
(RLU), adjusted to 1. *: P < 0.05; ns: P > 0.05. (B) THP-1 over-expressing indicated miR or scramble sequence 
were seeded and stimulated for 24 h with 1 µg/µL LPS (TLR4) or with 1 µg/µL Pam3CSK4 (TLR2). Cell-free 
supernatants were then collected and indicated cyokines and chemokines were quantified by ELISA. Datas from 
one single experiment are here shown. 
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shown in Figure 30A, luciferase assays confirmed miR-125a and let-7e inhibitory 
effects on CCL3 and CXCL8 3’UTRs, whereas TNFα 3’UTR was affected only by 
miR-125a and IL-6 by let-7e. The specificity of miR:3’UTR base-pairing was 
demonstrated by mutating the respective seed regions in every fusion gene construct. 
In order to confirm these and previous observations (Figure 20), the impairment in 
cytokines and chemokines production by THP-1 over-expressing single miR in 
comparison with control was investigated. As shown in Figure 30B, both miR-125a 
and let-7e over-expression in THP-1 led to a general TLR4 and TLR2 
unresponsiveness as compared to the control, suggesting a multi-targeting activity on 
entire pro-inflammatory signaling cascade, from ligand engagement (TLR4 
inhibition), to signaling transmission (not yet investigated) till pro-inflammatory 
mediators translation and production (Figure 30). 
  
Glucocorticoids up-regulate miR-511, a product of MRC1 gene locus 
miRNA genes are scattered in all chromosomes in humans except for the Y 
chromosome. Approximately 50% of known miRNAs are found in clusters (Lagos-
Quintana et al., 2001; Lau et al., 2001; Mourelatos et al., 2002) and they are 
transcribed as polycistronic primary transcripts (Lee et al., 2002). Several analyses of 
miRNA gene locations showed that the majority (∼70%) of mammalian miRNA 
genes are located in defined transcription units (TUs). It has been demonstrated that 
many miRNA genes were found in the introns in the sense orientation (Rodriguez et 
al., 2004). The major part of these intronic miRNAs are in the introns of protein-
coding genes, whereas few miRNAs are in the introns of noncoding RNAs 
(ncRNAs). In some cases, miRNAs are present in either an exon or an intron 
depending on the alternative splicing pattern. So, miRNA genes can be categorized 
based on their genomic locations: intronic miRNA in protein coding TU, intronic 
miRNA in noncoding TU and exonic miRNA in noncoding TU (Kim and Nam, 
2006).  
Recently, several microarray analysis of LPS or alternative stimuli-induced 
gene expression in human monocytes, macrophages or neutrophils have been 
published by our group (Martinez et al., 2006; Recalcati et al., 2010; Tamassia et al., 
2007). A collection of all these data was generated and a list of genes modulated in 
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response to pro- or anti-inflammatory mediators came out from this analysis. Taking 
advantage from Genome Browser database (http://genome.ucsc.edu/), we identified 
intronic miRNAs located in annotated genes in both protein coding and noncoding 
TU, confirming what have been already observed about miR-155 (O'Connell et al., 
2007) and miR-146a (Taganov et al., 2006). In Figure 31A, a part of the entire list is 
reported.  
Between all miRNAs listed, miRNA-511 leap at us as it is an intronic 
miRNA located in 5th intron of mannose receptor (known as MRC1 or CD206) 
(Figure 31B), a protein known to be expressed by monocytes and macrophages 
exposed to anti-inflammatory mediators (Fraser et al., 1998; Stein et al., 1992). It has 
also been shown to be up-regulated in tumour associated macrophages, as they 
acquire alternative polarization in tumour micro-environment (Allavena et al., 2010).  
Figure 31: miR-511 is located in mannose receptor 5th intron and both locus products are expressed in 
monocytes in a glucocorticoid-induced manner. (A) The table here reported correlate a selection of 7 
microRNAs and the affycode associated to their locus with expression variation in monocytes in response to LPS. 
Datas come from our pubblished observations. (B) A schematic representation of CD206/MRC1 gene locus is 
here reported. Squares represent exon (untranslated regions in white, coding sequence in black), triangles 
represent introns, red line represents miR-511 as indicated. (C) Freshly isolated monocytes were stimulated with 
10-5 M dexamethasone and collected at indicated time points. Total RNA was extracted and miR-511 and CD206 
(MRC1) expression was analyzed by RT-qPCR as indicated in Materials and Methods. Results are reported as 
fold change respect to unstimulated cells after normalization on snRNU6 levels. 
 
Among several anti-inflammatory cytokines responsible of mannose receptor 
gene induction (Martinez et al., 2009), glucocorticoids have also been reported to 
induce MRC1 gene expression in vitro in human peripheral blood monocytes after 
16-48 h exposure (Hogger et al., 1998; van der Goes et al., 2000). Therefore, 
expression of both MRC1 gene and miR-511 were tested in RNA extracted from 
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human peripheral blood monocytes treated with glucocorticoids 
(Dexamethasone/DEXA) at different time points. As shown in Figure 31C, both 
microRNA and its host gene were significantly up-regulated already after 12 h of 
stimulation. 
 
In silico analysis predicted and functional assays confirmed TGFβ  signaling 
cascade affection by miR-511 
The most peculiar feature of microRNAs is that a single miR interacts and 
consequently modulates large panel of targets. An analysis similar to that applied on 
LPS-dependent IL-10-potentiated microRNAs putative targets genes with the 
Ingenuity Pathway software (IPA) was performed on the miR-511 targets list 
generated by TargetScan. We identified a list of signaling pathways “affected” by 
miR-511. In this list, the most represented pathway was the TGFβ signaling pathway, 
with 25 different predicted target molecules (highlighted in red in Figure 32). 
 
Figure 32: miR-511 targeting of TGFβ signaling pathway. A list of putative target molecules of miR-511 
generated by TargetScan software was integrated with IPA “canonical pathways” informations. A schematic 
representation of TGFβ signaling pathway is reported. Putative targets of miR-511 are highlighted here in red. 
 
In order to verify in silico analysis prediction, we generated a cellular model 
by infecting the human monocytic cell line THP-1 with lentiviral particles sustaining 
constitutive expression of miR-511 or a scramble sequence as a control together with 
EGFP (Figure 19A). The constitutive expression of EGFP protein and microRNA-
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511 was tested by FACS analysis (not shown) and qRT-PCR (TaqMan microRNA 
Assay, Figure 33A), respectively. We then performed some cell-based assays to test 
the ability of infected THP-1 to respond to TGFβ, such as apoptosis assay (Figure 
33B) and gene expression analysis (Figure 33C). In the former, THP-1 cells were 
exposed to two different apoptosis inducing stimuli, such as starvation (RPMI 
without FBS) or 10 ng/ml TGFβ. THP-1 that constitutively produced microRNA-511  
Figure 33: miR-511 dampens TGFβ cellular response in THP-1 over-expressing cells. (A) THP-1 infected 
with lentiviral particle carrying miR-511 genomic region or scramble sequence were lysed with TRIZOL reagent 
and total RNA was extract. miR-511 expression levels was analyzed by RT-qPCR as indicated in Materials and 
Methods. Datas were normalized with 2-ΔCt method on snRNU6 levels as housekeeping. (B, C) THP-1 over-
expressing miR-511 or a scramble sequence were starved and then seeded in normal medium, in medium without 
FBS or with 10 ng/µL TGFβ for 48 h. (B) Apoptosis grade were analyzed with Annexin-V staining. FACS 
analysis was performed. Results are shown here as percentage (mean ± SEM, n = 3) of annexin-V positive and 7-
AAC negative cells (early apoptotic cells). (C) Total RNA was extracted and genes expression was analyzed as 
described in Materials and Methods. Datas were normalized with 2-ΔCt method on GAPDH levels as 
housekeeping. Empty bars represents unstimulated cells, fill bars cells stimulated with 10 ng/ml TGFβ. 
 
showed a lower amount of apoptotic cells (Annexin V positive and PI negative cells) 
only if stimulated with TGFβ, whereas starvation induced similar apoptosis grade in 
both infected cell types. In the latter experiment, IL-1β and Serpine1 mRNA were 
measured as indicators of TGFβ induced gene expression, whereas SMAD2 mRNA 
was considered an internal control, as its expression does not change after TGFβ 
exposure. As shown in Figure 33C, THP-1 that constitutively express miR-511 
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displayed a gene expression impairment if compared to the control. Taken together, 
these data suggest that THP-1 over-expressing miR-511 showed a diminished TGFβ-
induced cellular responses.  
After TGFβ receptor activation, SMADs protein are phosphorylated and 
eterodimerize with SMAD4 to translocate in the nucleus and start gene transcription 
(Ten Dijke et al., 2002). TGFβ receptor cross-phosphorylation also causes 
engagement of TGFβ activated kinase 1 (TAK1) that works as a bridge between 
classical TGFβ signaling pathway and MAPKs cascade (Sakurai et al., 2002). We 
therefore performed phosphorylation assays by western blot analysis on control 
THP-1 versus miR-511 over-expressing THP-1 to clarify which harm of TGFβ 
signaling pathway is most affected by the presence of miR-511 (Figure 34). As 
highlighted in Figure 34A and 34B, miR-511 over-expression in THP-1 monocytic 
cells completely abolished MAPKs activation, whereas slightly reduces SMAD2 
phosphorylation (Figure 34C). SMAD3 activation were not affected by miR-511 
presence in the cells. Taken together, all these data suggests that miR-511 over-
expression in the monocytic cell line THP-1 attenuates TGFβ signaling and its 
biological activity, operating a strong inhibition of SMAD-independent signaling 
pathway.  
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Figure 34: miR-511 inhibits Erk and p38 MAPK activation but not Smad2 or Smad3 phosphorylation. 
THP-1 over-expressing miR-511 or a scrable sequence were stimulated at indicated time points with 10 ng/µL 
TGFβ. 35 µg of whole-cell extracts were then loaded on a SDS-PAGE gel and membrane immuoblotted with 
anti-phospho-p38 Abs (A), anti-phospho-ERK1/2 (C) and anti-vinculin Abs (A, C), anti-phospho-Smad2 (B), 
anti-phospho-Smad3 (D) and anti-total Smad2 (B, D). ECL was then added and proteins detected by 
chemioluminescence. ImageJ software was then used to quantify the chemioluminescence intensity. Datas are 
presented as ratio between indicated protein and housekeeping. Intensity Ratio was calculated as mean ± SEM of 
three independent experiments (A, C), of one single experiment (B) or two independent experiments (D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion and future perspectives 
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As already discussed here and as this work demonstrated in several ways, 
microRNAs can be considered as master regulators of innate immune cells function. 
Starting from the seminal work of Taganov and colleagues (Taganov et al., 2006), it 
was clear to all scientific community that microRNAs play an important role in 
modulating and tuning every step in inflammatory reaction. 
In this work we firstly described TLR4-dependent modulation of microRNA 
profile in two primary innate immunity cell types, represented by monocytes and 
neutrophils. A low-density TaqMan-based array was performed on monocytes and 
neutrophils stimulated for 8 h with LPS and microRNAs expressed by stimulated 
cells were compared to unstimulated controls. This experiment confirmed miR-155, 
miR-146a and miR-132 expression induction in human peripheral blood monocytes, 
previously observed by Taganov et al. in the THP-1 human monocytic cell line 
(Taganov et al., 2006), but also identified miRNAs never reported before in this 
context, including miR-187, the miR-99b~7e~125a cluster, miR-9/9*, miR-135a and 
miR-222 in monocytes, and miR-196a and miR-9/9* in neutrophils. No down-
regulated miRs were observed. In order to confirm our analysis and to better 
characterize miRs induction, cells were stimulated and miR expression singularly 
analysed at different time points. All up-regulated miRs were confirmed, except for 
miR-135a and miR-222 in monocytes and miR-196a in neutrophils, and all of them 
showed a relatively slow kinetic, with the remarkable exception of miR-155, which 
appear as the only miR greatly induced at very short (2 h) time-point after LPS 
stimulation. 
This experiment identified miR-9/9* as the only LPS-induced microRNA in 
both monocytes and neutrophils. miR-9 was firstly observed as a fundamental 
regulator in neurons development, where it is involved in a double negative feedback 
loop with the transcription factors REST and CREB, the first responsible of 
inhibition of neurogenesis and direct target of miR-9 and the latter implicated in 
inducing miR-9 and, thus, neural development (Smirnova et al., 2005; Wu and Xie, 
2006). The fundamental role of miR-9 in the nervous system development was then 
confirmed by the phenotype of a miR-9 knockout mouse (Shibata et al., 2011). A 
role for miR-9 in immune system was also already reported, as it was found to down-
regulate the transcription factor PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells, 
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thus interfering with normal B cell terminal differentiation and contributing to the 
pathogenesis of Hodgkin lymphoma (Nie et al., 2008). Finally, miR-9 misregulation 
was observed in several tumours. Nevertheless, our identification of miR-9 as an 
LPS-responsive miRNA in human PMN and monocytes represents the first evidence 
linking miR-9 to the innate immune response. 
To further investigate miR-9 biology in the context of innate immunity, its 
regulation was then investigated. In human monocytes and neutrophils, TRL4 
engagement triggers different signaling cascades depending on the MAL/MyD88 or 
TRAM/TRIF adaptor molecules, the first being responsible of activation of NF-κB 
and MAPK signaling cascade, the latter recognized as type I IFN expression 
activator. Different TLRs can activate MyD88 with (TLR2) or without (TLR7/8) 
MAL scaffolding property or can selectively signal through TRAM/TRIF adaptors 
(TLR3). We observed that agonists inducing TLR2 or TLR7/8 triggering are also 
able to up-regulate miR-9 expression, whereas TLR3 agonists are not. In line with 
previous observations, TLR3 induced a signaling pathway responsible for miR-155 
expression only in monocytes, as neutrophils do not express TLR3 receptor. miR-9 
expression was also activated stimulating monocytes and neutrophils with TNFα and 
IL-1β. These observation, together with the late kinetic in miR-9 expression, argued 
against the possibility of a TNFα-dependent autocrine loop acting on monocytes and 
neutrophils, as previously reported for miR-155 (O'Connell et al., 2007), and this 
hypothesis was definitively put aside when incubation of monocytes with anti-TNFα 
antibody completely blocked TNFα-induced but not LPS-induced miR-9 expression. 
TNFα and TLR engagement are both responsible of NF-κB and MAPK activation, 
though through different signaling pathways. Our data suggested the possibility that 
miR-9 expression was NF-κB and/or MAPK activation-dependent. Consistent witht 
this, pre-incubation of monocytes and neutrophils with three different NF-κB 
inhibitors (MG-132, BAY-117082 and PDTC) completely blocked miR-9 induction, 
while inhibition of p38 (SB-203580) or JNK (SP-600125) were ineffective, 
demonstrating that NF-κB-activation is required for miR-9 up-regulation. 
In the human genome, three different pri-miR-9 precursors exist, encoded as 
intronic miR by three different genes. We investigated all three potential precursors 
and demonstrated that LPS exclusively induced transcription of the C1orf61 gene, 
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using two different transcriptional units called CROC-4a and CROC-4b equally 
contributing to miR-9 induction in response to LPS. Thus, LPS induce production of 
miR-9-1 by two transcripts derived from the C1orf61 gene. Of note, the role of miR-
9 in the development of nervous system has recently been ascribed to miR-9-2 and 
miR-9-3, while miR-9-1 was found not to be expressed in the CNS. Thus, the three 
miR-9 encoded by the human genome have evolved distinct functions in different 
tissues and biological processes. 
microRNAs mechanism of action is now well characterized. Several studies 
analysed microRNA-induced transcriptome and proteome variations (Selbach et al., 
2008), concluding that a single miR can modulate hundreds of targets in the cell. 
This result is due not only to the degenerated nature of miRNA-mRNA target 
recognition, as only 6-8 nucleotides are sufficient to guarantee miRNA-dependent 
inhibition, but also to the evolutionarily dictated ability of miRNAs to preferentially 
target transcription factors (Asirvatham et al., 2008). These observations, together 
with the already demonstrated ability of miR-9 to inhibit transcription factors 
involved in neurogenesis (Wu and Xie, 2006), drove us to concentrate our attention 
on transcription factors predicted to be targets of miR-9. Among these, the NF-κB1 
molecule, a Rel family member involved in NF-κB transcription activity. In 
particular, NFKB1 mRNA translates for two different isoforms, a full-length p105 
isoform and a smaller protein of 50 kDa (p50). As p105, NF-κB1 has inhibitory 
function, acting like an IκB protein. Once processed, p50 can heterodimerize, usually 
with p65, to induce gene expression. In the cell, the ratio between p105 and p50 
designs its function. A seed region of miR-9 is present in the 3’untranslated region of 
NFKB1 mRNA and its activity was tested in a luciferase assay on both wild-type and 
mutated form of the 3’UTR, confirming strong miR-9 activity and binding 
specificity. 
After LPS exposure, human monocytes induce a wide transcription 
activation, in part due to NF-κB activation. We demonstrated that also NFKB1 
mRNA levels are enhanced as a part of this transcriptional program, but 
unexpectedly the NF-κB1/p105 protein amount did not change. This expression 
pattern completely fits with microRNA-induced gene expression regulation, as they 
are known to be responsible in maintenance of cellular homeostasis avoiding 
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undesired protein over-expression. miR-9-induced inhibition of p105/p50 protein 
translation was therefore tested transfecting miR-9 expressing plasmid or its control 
in freshly purified human monocytes, establishing its negative control on NF-κB1 
protein translation.  
In summary, TLRs engagement induces a wide change in gene transcription, 
particularly due to NF-κB family members activation. As NF-κB1 can have different 
functional effects based on its relative expression in the cell, its levels must be finely 
regulated. p105 itself was observed working as IκB family proteins. p50 
homodimers, lacking a transciption activation domain, function as repressors, 
whereas heterodimers act as transcription activators. On the basis of our observation, 
miR-9 expression is one of the mechanisms that both monocytes and neutrophils may 
use to manage p105 production and therefore p105/p50 ratio in the cells, thus 
allowing the proinflammatory phase of the LPS response to correctly proceed. 
 
IL-10 is a key molecule in the control of an inflammatory response and it is 
among those genes overexpressed in monocytes exposed to pro-inflammatory 
stimuli. Its anti-inflammatory properties, together with its prompt release after TLR 
triggering, make it one of the most important autocrine negative feedback 
mechanism in resolving acute inflammation. Recently, an IL-10-dependent miR-155 
expression inhibition was observed in murine macrophages (McCoy et al., 2010). IL-
10-induced transcription variation of LPS-induced miRNAs was therefore tested. 
Our data support a complex modulation of LPS-induced microRNA exerted by IL-
10. miR-155 expression inhibition was confirmed also in freshly isolated human 
monocytes, together with the down-modulation of miR-146a and miR-9. By contrast, 
miR-146b, miR-99b~7e~125a cluster and miR-187 are strongly induced by 
costimulation of LPS and IL-10, and miR-146a is induced also by IL-10 itself. 
To understand whether LPS-induced miR-187 and miR-99b~7e~125a cluster 
induction was due to the autocrine effect of IL-10 on monocytes, an inhibition of the 
IL-10 receptor was obtained by pre-treating monocytes with an IL-10R-blocking 
antibody before LPS stimulation. Avoiding IL-10 triggering of its receptor, miR-187 
strong induction was completely blocked and a similar effect on miR-99b~7e~125a 
cluster was observed. Conversely, LPS effect on miR-155 was potentiated, 
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confirming the inhibitory role of IL-10 on this miR. While miR-187 is generated by 
processing of a precursor located in an intergenic region on chromosome 18, the 
miR-99b~7e~125a cluster comes from a common precursor located upstream a long 
non-coding RNA (UNQ2487). Expression analysis of these microRNAs and their 
neighbour ncRNA point to their co-expression, but further experiments, such as 
expression kinetic, are required. 
In 2010, in a brilliant review on miRNA regulation of transcription, Inui and 
colleagues suggested that rather than looking for miRNA-target pairs to predict 
miRNA biological finctions, researchers should ask which biological processes 
might be prime candidates for miRNA-mediated regulation. In this perspective, 
signaling complexes are highly dynamic and are able to translate stimuli into well-
established dose-dependent responses. Hence, signal transduction pathways result as 
prime candidates for miRNA-mediated regulation in animal cells, as the multi-
targeting capacity of miRNAs make them able to remodel the signaling landscape, 
facilitating or opposing the transmission of information to downstream effectors in a 
desirable manner. Taking advantage of the on-line software TargetScan to predict 
miRNA targets and of the Ingenuity Pathway (IPA) software to allocate genes in 
well-established signaling pathways, a list of signaling cascades affected by miR-187 
and miR-99b~7e~125a cluster was generated. Among several signaling pathways, 
the TLR signaling pathway emerged for the multi-targeting activity of these miRs. 
Subsequent experiments confirmed the capacity of both miR-187 and the cluster to 
impact on the acute inflammatory response, as the THP-1 monocytic cell line 
transduced with miR-187 or the cluster showed inhibition of TLR4 and TLR2-
dependent pro-inflammatory cytokines (TNFα and IL-6) and chemokines (CCL3 and 
CXCL8). Similar results were observed stimulating miR-99b~7e~125a cluster 
overexpressing THP-1 with TLR4 and TLR2 agonists and IFNγ using CXCL10 
production as a read-out. CXCL10 was previously shown to be a potent effector of 
IFN-antiviral response (Qi et al., 2009) and therefore produced by THP-1 cells also 
in response to both TLR agonists and type II interferon. Confirming its role as 
negative regulator of reaction against invading pathogens, miR-187 over-expression 
inhibited TLR4 and TLR2-dependent but not IFNγ-induced CXCL10 production. In 
parallel, over-expression of miR-125a and let-7e exerted different function in 
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response to these stimulations. Indeed, miR-125a show the same capacity of the 
entire cluster overexpression in impairing TLR2 and TLR4-induced response, 
whereas let-7e over-expression influenced only TLR4 signaling pathway, as already 
published (Androulidaki et al., 2009), demonstrating to be ineffective in inhibiting 
TLR2-dependent CXCL10 production. As for miR-187, IFNγ stimulation was not 
affected by miRs overexpression. Further experiments are needed to verify miR-99b 
contribution in miR cluster global impairment of inflammatory stimulations. 
As for miR-9, the list of miR-187 putative targets was screened in search of 
transcription factors known to be involved in the inflammatory process. Among 
these, the atypical member of NF-κB inhibitors IκBs family IκBζ attracted our 
attention. IκBζ has been shown to be required for LPS-dependent IL-6 transcription 
and production (Kitamura et al., 2000; Seshadri et al., 2009; Yamamoto et al., 2004), 
and its prompt induction after LPS triggering is negatively modulated by IL-10. 
Several lines of evidence suggested miR-187 as a regulator of IκBζ expression and 
function. First, we observed an inverse correlation of miR-187 and NFKBIZ mRNA 
expression. Second, miR-187 overexpression inhibited translation of the IκBζ 3’UTR 
reporter construct, demonstrating binding specificity as deletion of miR-187 seed 
region completely restored the expression of the reporter gene. Third, forced 
expression of miR-187 in freshly purified human monocytes significantly inhibits 
LPS-dependent IκBζ up-regulation. Fourth, in a complementary approach, inhibition 
of the LPS- or LPS plus IL-10-dependent miR-187 expression induces IκBζ up-
regulation. Fifth, transfection of miR-187 mimic effects on IL-6 transcription and 
production overlap with knock down of IκBζ with siRNA technology, while it has no 
effect on IL-10 production, demonstrating the specific activity of miR-187 on IκBζ 
protein. 
The miR-187-driven inhibition of IκBζ, however, is not sufficient to explain 
the global impairment in TLR response observed in miR-187 overexpressing THP-1 
cells. This phenotype can be partially explained by the proven capacity of miR-187 
to directly target TNFα mRNA and therefore inhibit its production, here uncovered 
by using luciferase reporter assay and transfecting freshly purified monocytes both 
with miR mimic and with anti-sense miR. TNFα has been already shown to induce a 
great number of pro-inflammatory events, including activation of key transcription 
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factors such as NF-κB, AP-1 and p38 activation, all fundamental for transcription 
activation and production of inflammatory cytokines and chemokines (Aggarwal, 
2003). Therefore, an inhibition in TNFα release can easily result in abrogation of a 
fundamental positive feedback loop in the production of inflammatory mediators. 
Our data suggesting a significant role of the miR-99b~7e~125a cluster in 
acute inflammatory response prompted us to further investigate the role of these 
molecules in the immune system. As far as let-7 family members, 13 genomic loci, 
some of which clustered together have been identified, but as some of these loci 
encode identical mature miRNAs the number of distinct mature let-7 miRNAs stands 
at ten: let-7a through let-7i plus the related miR-98 and miR-202. The mature let-7a 
is identical across animal species from C. elegans to humans, while the other family 
members share the seed sequence but differ in the remaining nucleotides to varying 
extents. These miRs are expressed in various different adult tissues. In contrast to 
their expression in differentiated tissues, mature let-7 family members are absent in 
human and mouse embryonic stem cells or pluripotent cell populations, and 
increasing expression upon differentiation seems to be a common theme (Bussing et 
al., 2008). Recent publications sustain a role for let-7 members in the immune 
system, as some members of these family are regulated in several inflammatory 
contests (Androulidaki et al., 2009; Chen et al., 2007b; Satoh et al., 2011; Sharbati et 
al., 2011; Zhang et al., 2011), some members were shown to directly regulate TLR4 
receptor expression, thus modulating macrophage and dendritic cell responses to 
LPS (Androulidaki et al., 2009; Chen et al., 2007b; Satoh et al., 2011), and let-7b and 
let-7i were shown to modulate cytokine production by direct targeting IFNβ and 
SOCS1, respectively (Sharbati et al., 2011; Zhang et al., 2011). Conversely, a poor 
literature is presently available on the miR-99 family members, miR-99a and miR-
99b, which seem to be involved in positive or negative regulation of tumour 
development, depending on cancer progression and types (Witwer et al., 2010). Also 
the miR-125a was first identified as an oncosuppressor miRNA, as several study 
reported its capacity to induce apoptosis or inhibit metastatic potential of cancer cells 
(Guo et al., 2009; Li et al., 2009); (Jiang et al., 2011; Wang et al., 2009), and a 
polimorphism located in the eighth nucleotide of the mature miR form was 
associated with breast cancer risk in different countries (Peterlongo et al., 2011). 
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Very recently, miR-125a was also linked to macrophage biology, as it is up-regulated 
in response to different pathogens (Monk et al., 2010; Schnitger et al., 2011) and has 
been shown to play a non-redundant role in hematopoiesis (Gerrits et al., 2011; Guo 
et al., 2010). Notably, Zhao and colleagues observed an increased production of 
CCL5 in the contest of systemic lupus erythematosus and linked this phenomenon to 
the up-regulation of KLF13, a transcription factor responsible of CCL5 transcription, 
as a consequence of miR-125a down-modulation (Zhao et al., 2010). Also the other 
miR-125 family member, miR-125b, is well known to be involved in cancer and 
immunity biology. First identified as involved in cancer regression (Ozen et al., 
2008; Visone et al., 2007), growing evidence indicate miR-125b as a master 
regulator of both transcription factors (Bak1, Stat3, IRF4; (Chaudhuri et al., 2011; 
Surdziel et al., 2011) and immune mediators (TNFα; (Tili et al., 2007). Curiously, 
miR-125b is down-modulated by LPS, opposite to our observation of miR-125a 
being induced (Androulidaki et al., 2009; Tili et al., 2007). As the cluster product 
with the highest predicted amount of targets involved in the immune response, our 
attention was concentrated on miR-125a. A seed region for miR-125a was detected 
both in TLR4 and in its co-receptor CD14 3’UTRs and luciferase reporter assays 
demonstrated activity and binding specificity to these two regions. FACS analysis of 
miR-125a overexpressing THP-1 monocytic cells confirmed the negative regulation 
exerted by this microRNA on the two receptor molecules. TLR4 inhibition, however, 
is not sufficient to explain the miR-125a-induced impairment in both TLR2 and 
TLR4 cellular response. In 2007, Tili and colleagues demonstrated in murine 
macrophages how miR-125b and miR-155 collaborate in negatively and positively 
regulating TNFα mRNA translation, respectively. Our experiments confirmed the 
ability of miR-125a in inhibiting TNFα translation, acting both on receptor that 
induce its production (TLR4 and CD14) and on the cytokine itself. As hypothesized 
for miR-187, TNFα inhibition is sufficient to explain the spread miR-125a-dependent 
inhibition of cytokine and chemokine production. Moreover, we predicted and 
experimentally validated at least one seed region of miR-125a or let-7e in several 
proinflammatory cytokines and chemokines, with the exception of CXCL10. Hence, 
the miR-99b~7e~125a cluster show the unique feature in being direct inhibitor of 
both TLR4 receptor and several pro-inflammatory effectors. 
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In summary, our results highlight a novel set of microRNA induced by LPS 
and potentiated by IL-10 that operate a wide inhibition of the TLR4 function, from 
its expression to the ability to induce pro-inflammatory mediators transcription and 
production. These microRNAs qualify themselves as new anti-inflammatory 
weapons used by IL-10 to extinguish inflammation. 
 
In the last part of this thesis project, experiments have been focused on 
microRNAs regulation by glucocorticoids. In this respect, we identified miR-511 as 
a novel microRNA located in the fifth intron of the mannose receptor MRC1. This 
gene encodes for a protein known to be expressed by monocytes, up-regulated in 
their differentiation to macrophages and dendritic cells and over-expressed in 
response to anti-inflammatory stimuli (Martinez et al., 2009). Among anti-
inflammatory stimuli, glucocorticoids can induce MRC1 expression in human 
monocytes and macrophages. Concomitant up-regulation of miR-511 with its host 
gene was therefore tested and confirmed at different time points. 
Little is known about miR-511, except for a recently published paper 
describing miR-511 as a regulator of TLR4 protein expression (Tserel et al., 2011). 
To go deep in understanding its biological function, an analysis of its predicted target 
genes was conducted using the IPA software as described for miR-187 and cluster. 
Analysis revealed the TGFβ signaling pathway as one of the most affected among 
canonical pathways taken into account by IPA. Gene expression regulation, 
apoptosis and Smads/MAPK cascade activation are all know effects of TGFβ 
signaling. Results suggested a strong inhibition of TGFβ-dependent activation of 
both the Extracellular Signal-Regulated Kinases (ERK1/2) and p38 activation 
module by miR-511. These two modules are activated with different signaling 
mechanisms. The first is activated by Raf-Ras-MEK pathway, usually activated 
directly by tyrosin kinase receptor; the latter is activated by Smad-TAK1 activation 
together with JNK module. Preliminary results suggest inhibition of the three MAP 
kinases signaling cascades, but further experiment must be conducted to validate 
JNK1 and 3 activation. These results underline miR-511 as a new molecular 
mechanism used by glucocorticoids to control pro-inflammatory mediators release 
by inhibiting the MAPK cascade. Furthermore, in 2003 Peltier and colleagues 
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demonstrated that TGFβ, via upregulation of both Smad and MAPK signaling 
cascade, is also able to increase macrophages sensitivity to glucocorticoids. In this 
contest, our results could be considered as a negative feedback exerted by 
glucocorticoids to avoid excessive response of monocytes to their action. 
In conclusion, microRNAs function in every step of acute inflammation. LPS 
sensing induces upregulation of a set of microRNA, including miR-9, miR-155, miR-
146a and miR-132 that, in different ways, control pro-inflammatory mediators. At 
the same time, in a highly regulated and fine-tuned manner, anti-inflammatory 
effectors are produced. Acting in concert with the previously activated signaling 
pathways, these mediators induce a second set of microRNAs, including miR-187, 
miR-125a, let-7e and miR-99b, that by a multi-targeting strategy stop inflammation 
acting in particular on the NF-κB signaling pathway and on the final effectors 
themself. At the end, the systemic action of glucocorticoids allow the extinguishing 
of inflammation, turning off pro-inflammatory transcription factors and in turn 
activating their own transcription program that consist, among other genes, in at least 
one microRNA (miR-511) which inhibit TGFβ activity and prevent MAPK cascade 
further activation (Figure 35). 
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Figure 35. Schematic model of pro- and anti-inflammatory microRNAs impact on inflammation-driven 
signaling pathways uncovered with this work. TLR4 engagement triggers a complicate signaling cascade that 
induces miRs transcription (the uncovered action of miR-9 is here reported). TLR-dependent IL-10 release 
exherts a feedback activity up-regulating miR-187 and miR cluster that, in turn, inhibit excessive pro-
inflammatory mediators release. Finally, systemic production of cortisol induces miR-511 that negatively 
modulates SMAD and MAPK signaling pathways. 
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